SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 21, 1997
--------------------------------
VIRAGEN, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-10252 59-2101668
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission File (IRS Employer
or incorporation) Number) Identification No.)
2343 West 76th Street, Hialeah, Florida 33016
--------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code (305) 557-6000
-----------------------------
N/A
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5 - OTHER EVENTS
On February 21, 1997, the Company issued 5,000 shares of its Series E
Convertible Preferred Stock to State Capital Market Group, Ltd. in consideration
for $5,000,000. The Series E Preferred Stock provides for a dividend of 5% per
annum of the stated value of the Series E Preferred Stock on a cumulative basis.
Dividends accrue from the date of issuance and are payable quarterly commencing
April 1, 1997. Dividends may be paid in cash or, at the Company's option and
subject to certain other conditions, in shares of Common Stock of the Company.
Except as otherwise provided by law, the holders of Series E Preferred Stock do
not have voting rights. Upon liquidation, dissolution or winding-up of the
Company, no distribution may be made to the holders of shares of capital stock
ranking junior to the Series E Preferred Stock unless, prior thereto, the
holders of the Series E Preferred Stock shall have received $1,000 per share
plus an amount equal to declared and unpaid dividends thereon to the date of
such payment. A vote of not less than two-thirds of the then outstanding shares
of Series E Preferred Stock is required prior to any amendment, alteration,
change or repeal of any of the designations of the Series E Preferred Stock.
The Series E Preferred Stock (as represented by the stated value) is
convertible into shares of Common Stock of the Company commencing May 8, 1997 by
dividing the stated value of the Series E Preferred Stock to be converted by the
conversion price in effect at the time of conversion. The conversion price shall
be (i) the lesser of the market price for the Common Stock of the Company, as
defined in the Certificate of Designations, multiplied by 85%, subject to
adjustment, or (ii) $7.00, subject to adjustment. The Company also has the right
to compel conversion of the Series E Preferred Stock at any time subsequent to
270 days after February 21, 1997. The conversion price of the Series E Preferred
Stock is subject to adjustment under certain conditions including the time when
the Company completes the registration process for the resale of the shares of
Common Stock underlying the Series E Preferred Stock and the obtaining of any
required stockholder approval relevant to the transaction. The holder of the
Series E Preferred Stock may not convert the shares of Series E Preferred Stock
if, as a result thereof, the shares of Common Stock beneficially owned by the
holder would exceed 4.9% of the outstanding shares of Common Stock of the
Company. The Company has agreed to register the shares of Common Stock issuable
upon conversion of the Series E Preferred Stock with the Securities and Exchange
Commission.
The proceeds from the sale of the Series E Preferred Stock are expected to
be used for the continued development of the Company's OmniferonTM product
including the funding of European Union clinical trials, completion of the
Scottish production facility, pre-clinical Phase I and Phase II trials and Phase
III studies, the establishment of domestic manufacturing capacity, joint
research and development projects, product development research and general
working capital purposes. Placement fees of $300,000 were paid.
2
<PAGE>
ITEM 7 - FINANCIAL STATEMENTS, PROFORMA FINANCIAL INFORMATION AND EXHIBITS
EXHIBITS:
1. Certificate of Designation Preferences and Rights for Series E
Convertible Preferred Stock.
2. Securities Purchase Agreement dated as of December 31, 1996 and
related Registration Rights Agreement.
3
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
VIRAGEN, INC.
By: /s/ Dennis W. Healey
---------------------------------------
Dennis W. Healey, Executive Vice
President and Principal Financial Officer
DATED: March 6, 1997.
4
- --------------------------------------------------------------------------------
EXHIBIT (1)
Certificate of Designation Preferences
and Rights for Series E Convertible Preferred Stock
- --------------------------------------------------------------------------------
VIRAGEN, INC.
CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF
5% CUMULATIVE CONVERTIBLE PREFERRED STOCK, SERIES E
VIRAGEN, INC. (the "Company"), a corporation organized and existing
under the General Corporation Law of the State of Delaware, does hereby certify
that, pursuant to authority conferred upon the Board of Directors of the Company
by the Certificate of Incorporation, as amended, of the Company, and pursuant to
Section 151 of the General Corporation Law of the State of Delaware, the Board
of Directors of the Company at a meeting duly called and held on February 11,
1997, adopted resolutions providing for the designations, preferences and
relative, participating, optional or other rights, and the qualifications,
limitations or restrictions thereof, of Five Thousand (5,000) shares of 5%
Cumulative Convertible Preferred Stock, Series E of the Company, as follows:
RESOLVED, that the Company is authorized to issue 5,000 shares of 5%
Cumulative Convertible Preferred Stock, Series E, $1.00 par value (the
"Preferred Shares"), which shall have the following powers, designations,
preferences and other special rights:
(1) DIVIDENDS. The holders of the Preferred Shares shall be entitled
to cumulative dividends of five percent (5%) per annum of the Stated Value (as
defined below) of each Preferred Share. Dividends shall accrue from the date of
issuance of the Preferred Shares and shall be payable on each January 1, April
1, July 1 and October 1 commencing April 1, 1997, and in the case of conversion
of a Preferred Share shall be paid on the date of such conversion through and
including the date on which the Preferred Shares are converted. Dividends shall
be calculated on the basis of a year of 360 days consisting of 12 30-day months.
Dividends shall be paid in cash or, at the Company's option, in fully paid and
nonassessable shares of Common Stock valued based on the Average Market Price
(as defined herein) of the Common Stock for the period of five (5) consecutive
trading days ending on the trading day before the dividend payment date or the
date of conversion, as the case may be; PROVIDED, HOWEVER, that in no event
shall accrued dividends be paid in shares of Common Stock to any holder of
Preferred Shares if, after giving effect to such distribution, the number of
shares of Common Stock beneficially owned by such holder and all other persons
whose beneficial ownership of shares of Common Stock would be aggregated with
such holder's beneficial ownership of shares of Common Stock for purposes of
calculating beneficial ownership in accordance with Sections 13(d) and 16 of the
Securities Exchange Act of 1934, as amended, and the regulations thereunder
(collectively, "Sections 13(d) and 16")(each such other person a "Related
Person" of such holder) (other than shares of Common Stock deemed beneficially
owned through the ownership of unconverted Preferred Shares or unconverted
shares of the Company's 5% Convertible Cumulative Preferred Stock, Series B (the
"Series B Preferred Shares")) would exceed four and nine-tenths percent (4.9%)
<PAGE>
of the outstanding shares of Common Stock and cash shall be paid in lieu of any
shares which cannot be issued pursuant to this proviso. For purposes of the
proviso to the immediately preceding sentence, beneficial ownership shall be
determined in accordance with Sections 13(d) and 16, except as otherwise
provided with respect to unconverted Preferred Shares and Series B Preferred
Shares in the parenthetical clause of the proviso to the immediately preceding
sentence. Notwithstanding the foregoing, in no event shall accrued dividends be
paid in shares of Common Stock if, on the dividend payment date, such shares of
Common Stock would not be freely tradable because the registration statement
(the "Registration Statement") covering the shares of Common Stock issuable
hereunder and required to be filed by the Company pursuant to the Registration
Rights Agreement between the Company and the initial holder of the Preferred
Shares (the "Registration Rights Agreement") has not been declared effective by
the U.S. Securities and Exchange Commission ("SEC") (the date on which the
Registration Statement is declared effective by the SEC being hereinafter
referred to as the "Effective Date"), or if, after the Effective Date, sales of
shares of Common Stock cannot be made pursuant to the Registration Statement by
reason of a stop order, the Company's failure to update the Registration
Statement in accordance with the rules and regulations of the SEC or otherwise,
or if the Common Stock is not then listed or included for quotation on the
National Market of the National Association of Securities Dealers Automated
Quotation System (the "NASDAQ-NM"), the New York Stock Exchange (the "NYSE"),
the American Stock Exchange (the "AMEX"), the NASDAQ SmallCap Market (the
"NASDAQ SmallCap") or the NASDAQ Bulletin Board ("NASDAQ Bulletin Board"). The
Company shall not issue any fraction of a share of Common Stock in payment of a
dividend, but shall pay cash therefor. The Company shall, so long as any of the
Preferred Shares are outstanding, reserve and keep available out of its
authorized and unissued Common Stock, such number of shares of Common Stock as
shall from time to time be sufficient to pay dividends hereunder. Every
reference herein to the Common Stock of the Company (unless a different
intention is expressed) shall be to the shares of the Common Stock of the
Company, $.01 par value, as such stock exists immediately after the issuance of
the Preferred Shares provided for hereunder, or to stock into which such Common
Stock may be changed from time to time thereafter.
"Average Market Price" of any security for any period shall be
computed as the arithmetic average of the closing bid prices for such security
for each trading day in such period on the principal trading market for such
security (all as appropriately adjusted for any stock dividend, stock split
recapitalization, reorganization or other similar transaction during such period
or between the end of such period and the date of a conversion of Preferred
Shares or any dividend payment in shares of Common Stock, as applicable.)
(2) CONVERSION OF PREFERRED SHARES. The holders of the Preferred
Shares shall have the right, at their option, to convert the Preferred Shares
into shares of Common Stock on the following terms and conditions:
(A) CONVERSION RIGHT. Each Preferred Share shall be convertible at
any time after the seventy-fifth (75th) day following the date of original
2
<PAGE>
issuance of the Preferred Shares (or, if such Preferred Share is called for
conversion pursuant to Section 3 hereof, at any time up to and including, but
not after, the close of business on the fifth (5th) full trading day prior to
the date fixed for the conversion) into fully paid and nonassessable shares
(calculated to the nearest whole share) of Common Stock, at the conversion price
in effect at the time of conversion determined as hereinafter provided (the
"Conversion Price"); PROVIDED, HOWEVER, that in no event shall any Restricted
Person be entitled to convert Preferred Shares if, after giving effect to such
conversion, the number of shares of Common Stock beneficially owned by such
Restricted Person and all Restricted Persons whose beneficial ownership of
Common Stock would be aggregated with such Restricted Person's beneficial
ownership of Common Stock (other than shares of Common Stock deemed beneficially
owned through the ownership of unconverted Preferred Shares or unconverted
Series B Preferred Shares), would exceed four and nine-tenths percent (4.9%) of
the outstanding shares of Common Stock (calculated in accordance with Sections
13(d) and 16). For purposes of the proviso to the immediately preceding
sentence, beneficial ownership shall be determined in accordance with Sections
13(d) and 16, except as otherwise provided with respect to unconverted Preferred
Shares and Series B Preferred Shares in the parenthetical clause of the proviso
to the immediately preceding sentence. Each Preferred Share shall have a value
of One Thousand Dollars ($1,000) (the "Stated Value") for the purpose of such
conversion and the number of shares of Common Stock issuable upon conversion of
each Preferred Share shall be determined by dividing the Stated Value thereof by
the Conversion Price then in effect.
(B) CONVERSION PRICE. The Conversion Price shall be the lesser of
(i) an amount equal to the Average Market Price for the Common Stock for the
five (5) consecutive trading days ending one trading day prior to the date of
the Conversion Notice (as defined below) multiplied by (A) eighty five percent
(85%), subject to adjustment as provided herein, if on the date of the
Conversion Notice shares of Common Stock are traded on NASDAQ-NM or NASDAQ
SmallCap or (B) eighty percent (80%), subject to adjustment as provided herein,
if on the date of the Conversion Notice shares of Common Stock are traded on the
NASDAQ Bulletin Board (the percentage then in effect is referred to hereinafter
as the "Conversion Percentage"), or (ii) $7.00 (the "Fixed Conversion Price"),
subject to adjustment as provided herein.
(C) ADJUSTMENT TO CONVERSION PERCENTAGE AND FIXED CONVERSION PRICE.
If the Effective Date has not occurred within ninety (90) days after the date of
issuance of the Preferred Shares (which period shall be extended to the extent
that any delay in the occurrence of the Effective Date is attributable to the
action or inaction of the holders or their counsel in breach of the holders'
obligations to the Company), or if, after the Effective Date, sales cannot be
made pursuant to the Registration Statement by reason of an SEC stop order, the
Company's failure to update the Registration Statement in accordance with the
rules and regulations of the SEC or otherwise, or if the Common Stock is not
listed or included for quotation on the NASDAQ-NM, NYSE, AMEX, NASDAQ SmallCap
or NASDAQ Bulletin Board, then, as partial relief for the damages to the holder
by reason of any such delay in or restriction of its ability to sell the
underlying shares of Common Stock (which remedy shall not be exclusive of any
other remedies available at law or in equity):
3
<PAGE>
(i) The Conversion Percentage shall be reduced by a number of
percentage points equal to two (2) multiplied by the sum of: (i) the number of
periods of 30 consecutive days (prorated for periods of less than 30 consecutive
days) after the end of such 90-day period and prior to the Effective Date; (ii)
the number of periods of 30 consecutive days (prorated for periods of less than
30 consecutive days ) that sales cannot be made pursuant to the Registration
Statement (by reason of an SEC stop order, the Company's failure to update the
Registration or otherwise) or Rule 144 promulgated under the Securities Act of
1933, as amended (or successor rule or regulation, "Rule 144") after the
Effective Date; and (iii) the number of periods of 30 consecutive days (prorated
for periods of less than 30 consecutive days) that the Common Stock is not
listed or included for quotation on the NASDAQ-NM, NYSE, AMEX, NASDAQ SmallCap
or NASDAQ Bulletin Board after the Effective Date. (For example, if the
Effective Date occurs 45 days after the end of such 90-day period, the
Conversion Percentage would be 82% (under the circumstances set forth in Section
2(b)(i)(A)) or 77% (under the circumstances set forth in Section 2(b)(i)(B)
until any subsequent adjustment; if thereafter sales could not be made pursuant
to the Registration Statement for a period of 60 additional days, the Conversion
Percentage would then be 78% (under the circumstances set forth in Section
2(b)(i)(A)) or 73% (under the circumstances set forth in Section 2(b)(i)(B))).
If a holder converts Preferred Shares into Common Stock and an adjustment to the
Conversion Percentage is required subsequent to such conversion, but prior to
the sale of such Common Stock by such holder, the Company shall pay to such
holder, within five (5) days after receipt of a notice of the sale of such
Common Stock from such holder, an amount equal to the Average Market Price of
the Common Stock obtained upon conversion of such Preferred Shares for the five
(5) trading days ending one (1) trading day prior to the date of conversion
multiplied by two-hundredths (.02) times the number of periods of 30 consecutive
days (prorated for periods of less than 30 consecutive days) for which an
adjustment was required. Such amount may be paid at the Company's option in cash
or Common Stock the value of which is based on the Average Market Price of the
Common Stock for the period of five (5) consecutive trading days ending on the
date of the sale of such Common Stock; PROVIDED, HOWEVER, that any amounts due
as to that period during which the shares are not traded or included for
quotation on the NASDAQ-NM, NYSE, AMEX, NASDAQ SmallCap, or NASDAQ Bulletin
Board shall be paid in cash only; PROVIDED, FURTHER, HOWEVER, that in no event
shall shares be issued hereunder if, after giving effect to such issuance, the
number of shares of Common Stock beneficially owned by such holder and all
Related Persons of such holder (other than shares of Common Stock deemed
beneficially owned through the ownership of unconverted Preferred Shares or
unconverted Series B Preferred Shares) would exceed four and nine tenths percent
(4.9%) of the outstanding shares of Common Stock; cash shall be paid in lieu of
any shares which cannot be issued pursuant to this second proviso. For purposes
of the second proviso to the immediately preceding sentence, beneficial
ownership shall be determined in accordance with Sections 13(d) and 16, except
as otherwise provided with respect to unconverted Preferred Shares and Series B
Preferred Shares in the parenthetical clause of the second proviso to the
immediately preceding sentence. (For example, if the Conversion Percentage was
82% at the time of conversion of $1,000,000 in Stated Value of Preferred Shares
(such that such Preferred Shares were converted into Common Stock having an
4
<PAGE>
Average Market Price for the applicable period in aggregate of $1,219,512.10)
and subsequent to conversion there was a further delay of 60 days in the
Registration Statement's being declared effective, and such Common Stock was
sold at the end of such 60-day period, the Company would pay to the holder
$48,780.48 in cash or Common Stock) and
(ii) The Fixed Conversion Price as in effect from time to time shall
be reduced by two (2) percent multiplied by the sum of: (i) the number of
periods of 30 consecutive days (prorated for periods of less than 30 consecutive
days) after the end of such 90-day period and prior to the Effective Date; (ii)
the number of periods of 30 consecutive days (prorated for periods of less than
30 consecutive days) that sales cannot be made pursuant to the Registration
Statement (by reason of an SEC stop order, the Company's failure to update the
Registration or otherwise) or Rule 144 after the Effective Date; and (iii) the
number of periods of 30 consecutive days (prorated for periods of less than 30
consecutive days) that the Common Stock is not listed or included for quotation
on the NASDAQ-NM, NYSE, AMEX, NASDAQ SmallCap or NASDAQ Bulletin Board after the
Effective Date. (For example, if the Effective Date occurs 45 days after the end
of such 90-day period, the Fixed Conversion Price would be $6.79 until any
subsequent adjustment; if thereafter sales could not be made pursuant to the
Registration Statement for a period of 60 additional days, the Fixed Conversion
Price would then be $6.52.) If a holder converts Preferred Shares into Common
Stock and an adjustment to the Fixed Conversion Price is required subsequent to
such conversion, but prior to the sale of such Common Stock by such holder, the
Company shall pay to such holder, within five (5) days after receipt of a notice
of the sale of such Common Stock from such holder, an amount equal to the Fixed
Conversion Price then in effect multiplied by two-hundredths (.02) times the
number of periods of 30 consecutive days (prorated for periods of less than 30
consecutive days) for which an adjustment was required. Such amount may be paid
at the Company's option in cash or Common Stock whose value is based on the
Average Market Price of the Common Stock for the period of five (5) consecutive
trading days ending on the date of the sale of such Common Stock; PROVIDED,
HOWEVER, that any amounts due as to that period during which the shares are not
traded or included for quotation on the NASDAQ-NM, NYSE, AMEX, NASDAQ SmallCap
or NASDAQ Bulletin Board shall be paid in cash only; PROVIDED, FURTHER, HOWEVER,
that in no event shall shares be issued hereunder if, after giving effect to
such issuance, the number of shares of Common Stock beneficially owned by such
holder and all Related Persons of such holder would exceed four and nine tenths
percent (4.9%) of the outstanding shares of Common Stock (than shares of Common
Stock deemed beneficially owned through the ownership of unconverted Preferred
Shares or unconverted Series B Preferred Shares); cash shall be paid in lieu of
any shares which cannot be issued pursuant to this second proviso. For purposes
of the second proviso to the immediately preceding sentence, beneficial
ownership shall be determined in accordance with Sections 13(d) and 16, except
as otherwise provided with respect to unconverted Preferred Shares and Series B
Preferred Shares in the parenthetical clause of the second proviso to the
immediately preceding sentence.
5
<PAGE>
(D) ADJUSTMENT TO CONVERSION PRICE. In case the Company shall (i)
declare a dividend or make a distribution on the outstanding shares of its
Common Stock in shares of its Common Stock, (ii) subdivide its outstanding
shares of Common Stock into a greater number of shares, or (iii) combine its
outstanding shares of Common Stock into a smaller number of shares, the
Conversion Price in effect at the time of the record date for such dividend or
distribution or the effective date of such subdivision or combination shall be
proportionately adjusted so that the holder of any Preferred Shares converted
after such time shall be entitled to receive the aggregate number of shares of
Common Stock which the holder would have owned or been entitled to receive had
such Preferred Shares been converted immediately prior to such record date or
effective date and the resulting Common Stock had been subject to such dividend,
distribution, subdivision or combination. Such adjustment shall be made
successively whenever any event specified above shall occur.
(E) CONVERSION NOTICE. (1) The right of the holders of the Preferred
Shares to convert Preferred Shares shall be exercised by delivering to the
Company a notice stating the number of Preferred Shares to be converted (a
"Conversion Notice"). On presentation to the Company (or at any office or agency
maintained for the transfer of the Common Stock) of a Conversion Notice, the
holder of such Preferred Shares shall be entitled, subject to the limitations
herein contained, to receive a certificate or certificates for fully paid and
nonassessable shares of Common Stock in accordance herewith and cash for
fractional shares, of Common Stock on the foregoing basis. The Preferred Shares
shall be deemed to have been converted, and the person converting the same to
have become the holder of record of Common Stock, for all purposes as of the
close of business on the date of delivery of the Conversion Notice.
(2) If a holder of Preferred Shares elects to convert any Preferred
Shares in accordance with this Section 2, such holder shall not be required to
physically surrender the certificate for such Preferred Shares to the Company
unless all of the Preferred Shares represented by such certificate are being so
converted. Each holder of Preferred Shares and the Company shall maintain
records showing the number of Preferred Shares represented by each certificate
for Preferred Shares so converted and the dates of such conversions or shall use
such other method, reasonably satisfactory to the holder of such certificate and
the Company, so as not to require physical surrender of such certificate upon
each such conversion. In the event of any dispute or discrepancy, such records
of the Company shall be controlling and determinative in the absence of manifest
error. Notwithstanding the foregoing, if any portion of the Preferred Shares
represented by a certificate therefor is converted as aforesaid, the holder of
such certificate may not transfer the remaining shares represented by such
certificate unless such holder first physically surrenders such certificate to
the Company, whereupon the Company will forthwith issue and deliver upon the
order of such holder a new certificate, registered as such holder (upon payment
by such holder of any applicable transfer taxes) may request, representing in
the aggregate the remaining Preferred Shares represented by such certificates.
Each holder of Preferred Shares and any assignee, by acceptance of such
certificate, acknowledges and agrees that, by reason of the provisions of this
6
<PAGE>
paragraph, following conversion of a portion of the Preferred Shares represented
by such certificate, the number of Preferred Shares represented by such
certificate may be less than the number stated on the face thereof and the
Company may place a legend to that effect on the certificates for the Preferred
Shares.
(3) Upon receipt by the Company from the Holder of a telephone line
facsimile transmission of a Conversion Notice meeting the requirements for
conversion as provided in Section 2(e)(1), the Company shall issue and deliver
or cause to be issued and delivered to or upon the order of the holder
submitting such Conversion Notice certificates for the Common Stock issuable
upon such conversion within three business days after such receipt and otherwise
in accordance herewith and the Securities Purchase Agreement (including, without
limitation, in accordance with the requirement of the Securities Purchase
Agreement that certificates for shares of Common Stock issued on or after the
Effective Date upon conversion of Preferred Shares shall not bear any
restrictive legend). If a holder of Preferred Shares shall have given a
Conversion Notice as provided herein, the Company's obligation to issue and
deliver the certificates for Common Stock shall be absolute and unconditional,
irrespective of the absence of any action by the holder to enforce the same, any
waiver or consent with respect to any provision thereof, the recovery of any
judgment against any person or any action to enforce the same, any failure or
delay in the enforcement of any other obligation of the Company to such holder,
or any setoff, counterclaim, recoupment, limitation or termination, or any
breach or alleged breach by such holder of any obligation to the Company, and
irrespective of any other circumstance which might otherwise limit such
obligation of the Company to the Holder in connection with such conversion. If
the Company shall fail to issue and deliver or cause to be issued and delivered
the certificates for shares of Common Stock upon any such conversion as and when
required by the first sentence of this Section 2(e)(3), then, in addition to any
other liability which the Company may have to the holder, the Conversion
Percentage used to calculate the Conversion Price with respect to such
conversion shall be reduced by one percentage point for each day after the third
trading day following the date such Conversion Notice is received by the Company
to the date of delivery of such shares of Common Stock to such holder.
(F) MAJOR TRANSACTIONS. If the Company shall consolidate with or
merge into any corporation or reclassify its outstanding shares of Common Stock
(other than by way of subdivision or reduction of such shares), or in case of
any sale or transfer of all or substantially all of the assets of the Company,
or in the case of any share exchange pursuant to which all of the outstanding
shares of Common Stock are converted into other securities or property, (each a
"Major Transaction"), then the Company shall make appropriate provision or cause
appropriate provision to be made so that each holder of Preferred Shares shall
have the right thereafter to convert Preferred Shares into the kind of shares of
stock and other securities and property receivable upon such consolidation,
merger, sale, transfer or share exchange by the persons who were holders of
Common Stock immediately prior to the effective date of such consolidation,
merger, sale, transfer or share exchange and on a basis which preserves the
economic benefits of the conversion rights of the holder of Preferred Shares on
a basis as nearly as practical as such rights existed prior to such
7
<PAGE>
consolidation, merger, sale, transfer or share exchange. If, in connection with
any such consolidation, merger, sale, transfer or share exchange each holder of
shares of Common Stock is entitled to elect to receive either securities, cash
or other assets upon completion of such transaction, the Company shall provide
or cause to be provided to holders of Preferred Shares the right to elect the
securities, cash or other assets into which Preferred Shares shall be
convertible after completion of any such transaction on the same terms and
subject to the same conditions applicable to holders of the Common Stock
(including, without limitation, notice of the right to elect, limitations on the
period in which such election shall be made, and the effect of failing to
exercise the election). The Company shall not effect any such transaction unless
the provisions of this paragraph have been complied with. The above provisions
shall similarly apply to successive consolidations, mergers, sales, transfers or
share exchanges. The Company shall give the holders of the Preferred Shares
written notice of any Major Transaction promptly upon the execution of any
agreement whether or not binding in connection therewith (including without
limitation a letter of intent or agreement in principle) and in no event shall a
Major Transaction be consummated prior to forty-five (45) days after such
notice. Such notice shall specify the action proposed to be taken by the Company
and the date as of which holders of record of the Common Stock shall participate
in any such actions or be entitled to exchange their Common Stock for securities
or other property, as the case may be.
(G) RESERVATION OF SHARES. The Company shall, so long as any of the
Preferred Shares are outstanding, reserve and keep available out of its
authorized and unissued Common Stock, solely for the purpose of effecting the
conversion of the Preferred Shares, such number of shares of Common Stock as
shall from time to time be sufficient to effect the conversion of all the
Preferred Shares then outstanding.
(H) FRACTIONAL SHARES. The Company shall not issue any fraction of a
share of Common Stock upon any conversion, but shall pay in cash therefor at the
Average Market Price then in effect multiplied by such fraction. If a holder
converts more than one Preferred Share on the same date, any fractional share
otherwise issuable upon such conversion shall be determined by aggregating all
Preferred Shares converted by such holder on such date.
(I) TAXES. The Company shall pay any and all taxes which may be
imposed upon it with respect to the issuance and delivery of Common Stock upon
conversion of Preferred Shares as herein provided. The Company shall not be
required in any event to pay any transfer or other taxes by reason of the
issuance of such Common Stock in names other than those in which the Preferred
Shares surrendered for conversion are registered on the Company's records, and
no such conversion or issuance of Common Stock shall be made unless and until
the person requesting such issuance has paid to the Company the amount of any
such tax, or has established to the satisfaction of the Company and its transfer
agent, if any, that such tax has been paid.
(J) CONVERSION UPON FAILURE TO OBTAIN STOCKHOLDER APPROVAL.
Notwithstanding the applicable Conversion Price pursuant to this Section (2), in
the event any holder of Preferred Shares is unable to convert into shares of
8
<PAGE>
Common Stock the full amount of Preferred Shares held by such holder at the
Conversion Price by reason of the Company's failure to obtain Stockholder
Approval (as defined herein) or a waiver thereof from the National Association
of Securities Dealers, Inc. (the "NASD") as required by Rule 4460(i) of the
NASD, then the holder shall be entitled to convert any or all of its Preferred
Shares at a conversion price equal to the lesser of (i) the Fixed Conversion
Price, subject to adjustment as provided herein and (ii) the Average Market
Price for the Common Stock for the five (5) consecutive trading days ending one
trading day prior to the date of the Conversion Notice. As used in this Section
(2)(j), "Stockholder Approval" means the approval by a majority of the votes
cast by the holders of shares of Common Stock (in person or by proxy) at a
meeting of the stockholders of the Company (duly convened at which a quorum was
present), or a written consent of holders of shares of Common Stock entitled to
such number of votes given without a meeting, of the issuance by the Company of
20% or more of the outstanding Common Stock of the Company for less than the
greater of the book or market value of such Common Stock on conversion of the
Preferred Shares, as and to the extent required under Section 4460(i)(1)(D) of
the rules of the NASD (or any successor or replacement provision thereof).
(3) CONVERSION AT THE COMPANY'S OPTION. So long as at the time the
Company is in compliance in all material respects with its obligations under
this Certificate, the Registration Rights Agreement and the Securities Purchase
Agreement between the Company and the original holder of the Preferred Shares
pursuant to which the Company issued the Preferred Shares, the Company may, at
any time subsequent to two hundred seventy (270) days after the Effective Date,
require the holders of the then outstanding Preferred Shares to convert all, but
not less than all, of such Preferred Shares into Common Stock by delivering
written notice to such holders (the "Mandatory Conversion Notice") in accordance
with the terms hereof; PROVIDED, HOWEVER, that in no event shall the Company be
entitled to require any holder to convert its Preferred Shares if, and no such
conversion shall be effective to the extent that, after giving effect to such
conversion, the number of shares of Common Stock issued in such conversion and
otherwise beneficially owned by such holder and all Related Persons of such
holder, would exceed four and nine-tenths percent (4.9%) of the outstanding
shares of Common Stock (other than shares of Common Stock deemed beneficially
owned through the ownership of unconverted Preferred Shares or unconverted
shares of Series B Preferred Stock) and that as to those Preferred Shares which
the Company is prohibited from converting by operation of this proviso, the
Company's obligation to pay dividends thereon shall terminate as of the date of
the Mandatory Conversion Notice. For purposes of the proviso to the immediately
preceding sentence, beneficial ownership shall be determined in accordance with
Sections 13(d) and 16, except as otherwise provided with respect to unconverted
Preferred Shares and Series B Preferred Shares in the parenthetical clause of
the proviso to the immediately preceding sentence. The Conversion Price for the
purposes of this Section 3 shall be the lesser of (i) the product obtained by
multiplying the Average Market Price for the Common Stock for the five (5)
consecutive trading days ending one trading day prior to the conversion date
specified in the Mandatory Conversion Notice by the Conversion Percentage then
in effect, or (ii) the Fixed Conversion Price then in effect. Any Mandatory
Conversion Notice shall be given by telephone line facsimile transmission and
9
<PAGE>
U.S. mail to the holders of the then outstanding Preferred Shares at least
fifteen (15) trading days prior to the date fixed as the date for the conversion
thereof at their telephone line facsimile numbers and addresses provided to the
Company for such purpose and shall state that the then outstanding Preferred
Shares shall be converted at the Conversion Price in effect on the date fixed
for the conversion, upon the surrender, at the time and place designated in such
notice, of the certificates therefor. Within four (4) business days after the
date fixed for conversion, the Company shall deliver to the holders (i) that
number of shares of Common Stock for the Preferred Shares converted as shall be
determined in accordance herewith, and (ii) payment of the accrued and unpaid
dividends thereon (which payment of dividends may be made in shares of Common
Stock in accordance with Section 1 hereof if the requirements thereof are
satisfied). Notwithstanding the foregoing, if, at the time fixed for such
conversion, the Common Stock to be issued pursuant thereto is not listed or
included for quotation on the NASDAQ-NM, NYSE, AMEX, NASDAQ SmallCap or NASDAQ
Bulletin Board, then the Mandatory Conversion Notice shall be null and void.
(4) VOTING RIGHTS. Holders of Preferred Shares shall have no voting
rights, except as required by law and by Section 7 hereof.
(5) LIQUIDATION, DISSOLUTION, WINDING UP. In the event of any
voluntary or involuntary liquidation, dissolution or winding up of the Company,
the holders of the Preferred Shares shall be entitled to receive in cash out of
the assets of the Company, whether from capital or from earnings available for
distribution to its stockholders (the "Preferred Funds"), before any amount
shall be paid to the holders of the Common Stock, an amount equal to the Stated
Value per Preferred Share plus any accrued and unpaid dividends, provided that,
if the Preferred Funds are insufficient to pay the full amount due to the
holders of Preferred Shares and holders of shares of other classes or series of
preferred stock of the Company that are of equal rank with the Preferred Shares
as to payments of Preferred Funds (the "Pari Passu Shares"), then each holder of
Preferred Shares and Pari Passu Shares shall receive a percentage of the
Preferred Funds equal to the full amount of Preferred Funds payable to such
holder as a percentage of the full amount of Preferred Funds payable to all
holders of Preferred Shares and Pari Passu Shares. The purchase or redemption by
the Company of stock of any class, in any manner permitted by law, shall not,
for the purposes hereof, be regarded as a liquidation, dissolution or winding up
of the Company. Neither the consolidation nor merger of the Company with or into
any other corporation or corporations, nor the sale or transfer by the Company
of less than substantially all of its assets, shall, for the purposes hereof, be
deemed to be a liquidation, dissolution or winding up of the Company. No holder
of Preferred Shares shall be entitled to receive any amounts with respect
thereto upon any liquidation, dissolution or winding up of the Company other
than the amounts provided for herein.
(6) PREFERRED RANK. All shares of Common Stock shall be of junior
rank to all Preferred Shares in respect to the preferences as to distributions
and payments upon the liquidation, dissolution or winding up of the Company. The
10
<PAGE>
rights of the shares of Common Stock shall be subject to the preferences and
relative rights of the Preferred Shares. The Company may only authorize and
issue additional or other preferred stock which is of junior rank with the
Preferred Shares in respect of the preferences as to distributions and payments
upon the liquidation, dissolution or winding up of the Company. Notwithstanding
the foregoing, the Company may issue to the original holders of the Preferred
Shares or affiliates thereof preferred stock which is of equal rank with the
Preferred Shares in respect of the preferences as to distributions and payments
upon the liquidation, dissolution or winding up of the Company. In the event of
the merger or consolidation of the Company with or into another corporation, the
Preferred Shares shall maintain their relative powers, designations and
preferences provided for herein.
(7) VOTE TO CHANGE THE TERMS OF PREFERRED SHARES. The approval of
the Board of Directors and the affirmative vote at a meeting duly called by the
Board of Directors for such purpose or the written consent without a meeting of
the holders of not less than two-thirds (2/3) of the then outstanding Preferred
Shares shall be required to amend, alter, change or repeal any of the powers,
designations, preferences and rights of the Preferred Shares.
(8) REDEMPTION AT OPTION OF HOLDERS. (i) Each holder of Preferred
Shares shall be entitled, at such holder's option, by notice to the Company
given within 20 days after the occurrence of an Optional Redemption Event, to
require the Company to redeem all or a portion of such shares (but in no event
less than ten shares, unless such holder holds less than ten shares, in which
case the Company must redeem all of such holder's shares) upon the occurrence of
an Optional Redemption Event. An Optional Redemption Event means, during any
consecutive two month period, a change in a majority of either (a) the executive
officers or (b) the members of the Board of Directors of the Company from those
persons serving in such capacities at the beginning of such period. The Company
shall notify each holder of Preferred Shares within three (3) business days of
the occurrence of an Optional Redemption Event.
(ii) To exercise the optional redemption right, a holder of
Preferred Shares shall deliver to the Company a notice of redemption (an
"Optional Redemption Notice"), accompanied by the certificate for the Preferred
Shares to be redeemed. Any Optional Redemption Notice shall state (1) that the
holder delivering such notice is thereby requiring the Company to redeem
Preferred Shares pursuant to this Section (8) and (2) the number of Preferred
Shares held by such holder which are to be redeemed. In no event later than five
business days following receipt of such notice by the Company, the Company shall
make payment in immediately available funds of the applicable Redemption Price
with respect to the Preferred Shares to be redeemed to or upon the order of such
holder as specified by such holder in the Optional Redemption Notice. Upon
redemption of less than all of the Preferred Shares evidenced by a particular
certificate, promptly, but in no event later than five business days after
surrender of such certificate to the Company, the Company shall issue a
replacement certificate for the Preferred Shares which have not been redeemed.
Only whole shares of Preferred Stock may be redeemed.
11
<PAGE>
(iii) For purposes of this Section (8), "Redemption Price" with
respect to each Preferred Share to be redeemed shall mean an amount equal to the
sum of (A) $1,000 divided by the applicable Conversion Percentage and (B) all
dividends accrued and unpaid thereon to the applicable redemption date.
12
<PAGE>
IN WITNESS WHEREOF, the Company has caused this certificate to be
signed by Dennis W. Healey, its Executive Vice President, as of the _____ day of
February, 1997.
VIRAGEN, INC.
By:
Executive Vice President
13
- --------------------------------------------------------------------------------
EXHIBIT (2)
Securities Purchase Agreement dated as of December 31, 1996
and Registration Rights Agreement
- --------------------------------------------------------------------------------
SECURITIES PURCHASE AGREEMENT
SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of
December 31, 1996, by and between VIRAGEN, INC., a Delaware corporation, with
headquarters located at 2343 West 76th Street, Hialeah, FL 33016 (the
"Company"), and the undersigned (the "Buyer").
WHEREAS:
A. The Company and the Buyer are executing and delivering this
Agreement in reliance upon the exemption from securities registration afforded
by Rule 506 under Regulation D ("Regulation D") as promulgated by the United
States Securities and Exchange Commission (the "SEC") under the Securities Act
of 1933, as amended (the "1933 Act");
B. The Buyer wishes to purchase, in the amounts and upon the terms
and conditions stated in this Agreement, shares (the "Preferred Shares") of the
Company's 5% Cumulative Convertible Preferred Stock, Series E, $1.00 par value
(the "Preferred Stock"), which shall be convertible into shares (the "Conversion
Shares") of the Company's Common Stock, $.01 par value (the "Common Stock"), and
pursuant to which certain shares of Common Stock may be issued to the Buyer in
payment of dividends (the "Dividend Shares") and in accordance with Section 2(c)
of the Certificate of Designation, Preferences and Rights therefor (the
"Additional Shares"); and
C. Contemporaneously with the execution and delivery of this
Agreement, the parties hereto are executing and delivering a Registration Rights
Agreement, dated as of the date hereof (the "Registration Rights Agreement"),
pursuant to which the Company has agreed to provide certain registration rights
under the 1933 Act and the rules and regulations promulgated thereunder, and
applicable state securities laws;
NOW THEREFORE, the Company and the Buyer hereby agrees as follows:
1. PURCHASE AND SALE OF PREFERRED SHARES.
-------------------------------------
A. PURCHASE OF PREFERRED SHARES. The Company shall issue and sell to
the Buyer and the Buyer shall purchase 5,000 Preferred Shares which shall be
convertible into Conversion Shares in accordance with the terms of the
Certificate of Designations, Preferences and Rights of 5% Cumulative Convertible
Preferred Stock, Series E in the form attached hereto as EXHIBIT A (the
"Certificate of Designation"). Terms used herein without definition shall have
the meanings given them in the Certificate of Designation. The per share
purchase price of the Preferred Shares shall be One Thousand Dollars ($1,000).
B. FORM OF PAYMENT. Not later than the date which is two New York
Stock Exchange trading days after the date the Company and the Buyer shall have
executed and delivered, one to the other, this Agreement, the Buyer shall
deposit the purchase price for the Preferred Shares (the "Purchase Price") by
<PAGE>
delivering good funds in United States Dollars to the escrow agent (the "Escrow
Agent") identified in the Joint Escrow Instructions attached hereto as EXHIBIT B
(the "Joint Escrow Instructions"). Deposit of the Purchase Price by the Buyer
with the Escrow Agent shall be made by wire transfer of funds to:
Citibank, N.A.
153 East 53rd Street
New York, New York 10043
ABA#021000089
For Further Credit to A/C No. 37179446
For the account of Brian W. Pusch Attorney Escrow Account
Reference: Advantage/Viragen
Not later than the date which is two New York Stock Exchange trading days after
the date the Company and the Buyer shall have executed and delivered, one to the
other, this Agreement, the Company shall deliver to the Escrow Agent stock
certificates, duly executed on behalf of the Company, representing the Preferred
Shares (the "Stock Certificates"). By signing this Agreement, the Buyer and the
Company each agrees to all of the terms and conditions of, and becomes a party
to, the Joint Escrow Instructions, all of the provisions of which are
incorporated herein by this reference as if set forth herein in full.
C. CLOSING DATE. The date and time of the issuance and sale of the
Preferred Shares (the "Closing Date") shall be 12 noon, Eastern Standard Time,
on the date which is two New York Stock Exchange trading days after the date on
which the Buyer shall have deposited the Purchase Price with the Escrow Agent
under the Joint Escrow Instructions in accordance with Section 1(b) hereof, or
such other mutually agreed to time. The closing shall occur on the Closing Date
at the offices of the Escrow Agent.
2. REPRESENTATIONS, WARRANTIES, ETC. OF BUYER.
------------------------------------------
The Buyer represents and warrants to, and covenants and agrees with,
the Company as follows:
A. INVESTMENT PURPOSE. The Buyer is purchasing the Preferred Shares
for its own account or as fiduciary or agent for the account of one or more
institutional investors for investment only and not with a view towards, or for
resale in connection with, the public sale or distribution thereof except
pursuant to sales registered under the 1933 Act.
B. ACCREDITED INVESTOR STATUS. The Buyer and such institutional
account are "accredited investors" as that term is defined in Rule 501(a)(3) or
501(a)(8) of Regulation D.
C. RELIANCE ON EXEMPTIONS. The Buyer understands that the Preferred
Shares are being offered and sold to the Buyer or such account in reliance on
specific exemptions from the registration requirements of United States federal
and state securities laws and that the Company is relying on the truth and
2
<PAGE>
accuracy of, and the Buyer's and such account's compliance with, the
representations, warranties, agreements, acknowledgments and understandings of
the Buyer and such account set forth herein in order to determine the
availability of such exemptions and the eligibility of the Buyer and such
account to acquire the Preferred Shares.
D. INFORMATION. The Buyer and such account and their respective
advisors, if any, have been furnished with all materials relating to the
business, finances and operations of the Company and materials relating to the
offer and sale of the Preferred Shares which have been requested by the Buyer
and such account. The Buyer and such account and their respective advisors, if
any, have been afforded the opportunity to ask questions of the Company and have
received complete and satisfactory answers to any such inquiries. The Buyer and
such account understand that the investment in the Preferred Shares involves a
high degree of risk. The Buyer and such account have sought such accounting,
legal and tax advice as they have considered necessary to an informed investment
decision with respect to the acquisition of the Preferred Shares.
E. GOVERNMENTAL REVIEW. The Buyer and such account understand that
no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Preferred
Shares or the fairness or suitability of the investment in the Preferred Shares,
nor have such authorities passed upon or endorsed the merits of the offering of
the Preferred Shares.
F. TRANSFER OR RESALE. The Buyer and such account understand that
(i) except as provided in the Registration Rights Agreement, the Preferred
Shares, the Conversion Shares, the Dividend Shares and the Additional Shares
have not been and are not being registered under the 1933 Act or any state
securities laws, and may not be transferred unless (a) subsequently registered
thereunder, or (b) the holder thereof shall have delivered to the Company an
opinion of counsel, reasonably satisfactory in form, scope and substance to the
Company, to the effect that the securities to be sold or transferred may be
transferred pursuant to an exemption from such registration; (ii) any sale of
such securities made in reliance on Rule 144 promulgated under the 1933 Act may
be made only in accordance with the terms of said Rule and further, if said Rule
is not applicable, any resale of such securities under circumstances in which
the seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the 1933 Act) may require compliance
with some other exemption under the 1933 Act or the rules and regulations of the
SEC thereunder; and (iii) neither the Company nor any other person is under any
obligation to register such securities (other than pursuant to the Registration
Rights Agreement) under the 1933 Act or any state securities laws or to comply
with the terms and conditions of any exemption thereunder.
G. LEGEND. The Buyer and such account understand that the Preferred
Shares and, until such time as the Conversion Shares, the Dividend Shares and
the Additional Shares (the Conversion Shares, the Dividend Shares and the
Additional Shares are collectively referred to as the "Registrable Securities")
have been registered for resale under the 1933 Act as contemplated by the
Registration Rights Agreement, the stock certificates representing the
Registrable Securities shall bear a restrictive legend in substantially the
following form (and a stop-transfer order may be placed against transfer of such
stock certificates):
3
<PAGE>
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT") OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE
SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS,
OR AN OPINION OF COUNSEL IN FORM, SUBSTANCE AND SCOPE REASONABLY ACCEPTABLE TO
THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT OR UNLESS SOLD
PURSUANT TO RULE 144 UNDER THE ACT. ANY SUCH SALE, ASSIGNMENT OR TRANSFER MUST
ALSO COMPLY WITH APPLICABLE STATE SECURITIES LAWS.
The legend set forth above shall be removed and the Company shall issue a
certificate without such legend to the holder of the Preferred Shares upon which
it is stamped, if, unless otherwise required by state securities laws, (a) the
sale of such Preferred Shares is registered and effected under the 1933 Act, or
(b) in connection with a sale transaction, such holder provides the Company with
an opinion of counsel, in form, substance and scope reasonably acceptable to the
Company, to the effect that a public sale or transfer of the Preferred Shares
may be made without registration under the 1933 Act, or (c) such holder provides
the Company with reasonable assurances that the Preferred Shares can be sold
pursuant to Rule 144 under the 1933 Act (or a successor rule thereto) without
any restriction as to the number of securities acquired as of a particular date
that can then be immediately sold. Once the Registration Statement contemplated
by Section 2(a) of the Registration Rights Agreement shall have been declared
effective by the SEC, (1) the Company shall, upon request of the holder,
immediately remove any restrictive legend and terminate any stop-transfer
restriction for Registrable Securities issued prior to the date such
Registration Statement is declared effective by the SEC and (2) the Company
shall not place any restrictive legend or impose any stop-transfer restriction
on Registrable Securities issued thereafter.
H. AUTHORIZATION; ENFORCEMENT. This Agreement has been duly and
validly authorized, executed and delivered on behalf of the Buyer and is a valid
and binding agreement of the Buyer enforceable in accordance with its terms,
subject as to enforceability to general principles of equity and to bankruptcy,
insolvency, moratorium, and other similar laws affecting the enforcement of
creditors' rights generally.
I. RESIDENCY. The Buyer is a resident of that country specified in
its address on the signature page hereof.
3. REPRESENTATIONS, WARRANTIES ETC. OF THE COMPANY.
-----------------------------------------------
The Company represents and warrants to, and covenants and agrees
with, the Buyer as follows:
A. ORGANIZATION AND QUALIFICATION. The Company and its subsidiaries
are corporations duly organized, validly existing in good standing under the
4
<PAGE>
laws of the jurisdiction in which they are incorporated, except, in the case of
any such subsidiaries, as would not have a Material Adverse Effect (as defined
below), and have the requisite corporate power to own their properties and to
carry on their business as now being conducted. Each of the Company and its
subsidiaries is duly qualified as a foreign corporation to do business and is in
good standing in every jurisdiction in which the nature of the business
conducted by it makes such qualification necessary and where the failure so to
qualify would have a Material Adverse Effect. "Material Adverse Effect" means
any material adverse effect on the business, operations, properties, condition
(financial or other), results of operations or prospects of the Company and its
subsidiaries taken as a whole.
B. AUTHORIZATION; ENFORCEMENT. (i) The Company has the requisite
corporate power and authority to enter into and perform this Agreement and the
Registration Rights Agreement, and to issue the Preferred Shares and the
Registrable Securities in accordance with the terms hereof and thereof, (ii) the
execution and delivery of this Agreement and the Registration Rights Agreement
by the Company and the consummation by it of the transactions contemplated
hereby and thereby have been duly authorized by the Company's Board of Directors
and no further consent or authorization of the Company, its Board of Directors,
or its stockholders is required, (iii) this Agreement and the Registration
Rights Agreement have been duly executed and delivered by the Company, and (iv)
this Agreement and the Registration Rights Agreement constitute the valid and
binding obligations of the Company enforceable against the Company in accordance
with their terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally, the enforcement of creditors' rights and
remedies or by other equitable principles of general application.
C. CAPITALIZATION. As of December 31, 1996, the authorized capital
stock of the Company consists of (i) 50,000,000 shares of Common Stock of which
38,629,091 shares were issued and outstanding, and (ii) 1,000,000 shares of
preferred stock, $1.00 par value (the "Preferred Stock") of which 2,650 shares
were issued and outstanding and designated Series A Preferred Stock; 13,864
shares were issued and outstanding and designated Series B Preferred Stock; and
5,000 shares were issued and outstanding and designated Series C Preferred
Stock; and on the Closing Date there will be no material increase in the number
of shares of Common Stock or Preferred Stock outstanding other than 15,000
shares of Series D Convertible Preferred Stock issued in February 1997. All of
such outstanding shares have been validly issued and are fully paid and
nonassessable. No shares of Common Stock or Preferred Stock are subject to
preemptive rights or any other similar rights of the stockholders of the Company
or any liens or encumbrances. Except as disclosed in SCHEDULE 3(C), (i) there
are no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock in the Company or any of its
subsidiaries, or arrangements by which the Company or any of its subsidiaries is
or may become bound to issue additional shares of capital stock of the Company
or any of its subsidiaries, (ii) there are no outstanding debt securities, and
(iii) there are no agreements or arrangements under which the Company or any of
its subsidiaries is obligated to register the sale of its or their securities
5
<PAGE>
under the 1933 Act (except the Registration Rights Agreement, the several
Registration Rights Agreements, dated as of June 7, 1996, by and between the
Company and GFL Performance Fund Limited, GFL Advantage Fund Limited and Proton
Global Asset Management, LDC, the several Registration Rights Agreements dated
as of November 27, 1996 with the holders of Series C Convertible Preferred
Stock, the Registration Rights Agreement dated as of December 31, 1996 by and
between the Company and P.R.I.F., L.P. and the registration rights as described
in the final prospectus of Viragen (Europe) Ltd. dated July 12, 1996). The
Company has furnished to the Buyer true and correct copies of the Company's
Certificate of Incorporation, as amended, as in effect on the date hereof
("Certificate of Incorporation") and the Company's Bylaws, as in effect on the
date hereof (the "Bylaws"). The Company shall provide the Buyer with a written
update of this representation signed by the Company's Chief Executive or Chief
Financial Officer on behalf of the Company as of the Closing Date.
D. ISSUANCE OF SECURITIES. The Registrable Securities and Preferred
Shares are duly authorized and, upon issuance in accordance with the terms
hereof and thereof, shall be validly issued, fully paid and non-assessable, and
free from all taxes, liens and charges with respect to the issue thereof.
E. NO CONFLICTS. The execution, delivery and performance of this
Agreement, the Registration Rights Agreement and the Certificate of Designation
by the Company and the consummation by the Company of the transaction
contemplated hereby and thereby will not (i) result in a violation of the
Certificate of Incorporation or Bylaws or (ii) conflict with, or constitute a
default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which
the Company or any of its subsidiaries is a party, or result in a violation of
any law, rule, regulation, order, judgment, or decree (including federal and
state securities laws and regulations) applicable to the Company or any of its
subsidiaries or by which any property or asset of the Company or any of its
subsidiaries is bound or affected (except for such conflicts, defaults,
terminations, amendments, accelerations, cancellations and violations as would
not, individually or in the aggregate, have a Material Adverse Effect). The
business of the Company and its subsidiaries is not being conducted, and shall
not be conducted through the Registration Period (as defined herein), in
violation of any law, ordinance, regulation of any governmental entity, except
for possible violations which either singly or in the aggregate do not have a
Material Adverse Effect. Except as required under the 1933 Act and any
applicable state securities laws, the Company is not required to obtain any
consent, authorization or order of, or make any filing or registration with, any
court or governmental agency in order for it to execute, deliver or perform any
of its obligations under this Agreement, the Registration Rights Agreement and
the Certificate of Designation in accordance with the terms hereof and thereof.
F. SEC DOCUMENTS, FINANCIAL STATEMENTS. Since June 30, 1992, the
Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it with the SEC pursuant to the reporting requirements
of the Securities Exchange Act of 1934, as amended (the "1934 Act") (all of the
foregoing filed prior to the date hereof and all exhibits included therein and
6
<PAGE>
financial statements and schedules thereto and documents (other than exhibits)
incorporated by reference therein, being hereinafter referred to herein as the
"SEC Documents"). The Company has delivered to the Buyer true and complete
copies of the SEC Documents, except for such exhibits, schedules and
incorporated documents. As of their respective dates, the SEC Documents complied
in all material respects with the requirements of the 1934 Act and the rules and
regulations promulgated thereunder applicable to the SEC Documents, and none of
the SEC Documents, at the time they were filed with the SEC, contained any
untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading. As of
their respective dates, the financial statements of the Company included in the
SEC Documents complied as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC with
respect thereto. Such financial statements have been prepared in accordance with
generally accepted accounting principles, consistently applied, during the
periods involved (except (i) as may be otherwise indicated in such financial
statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or
summary statements) and fairly present in all material respects the financial
position of the Company as of the dates thereof and the results of its
operations and cash flows for the periods then ended (subject, in the case of
unaudited statements, to normal year-end audit adjustments). No information
provided by or on behalf of the Company to the Buyer and referred to in Section
2(d) of this Agreement contains any untrue statement of a material fact or omits
to state any material fact necessary in order to make the statements therein, in
light of the circumstance under which they were made, not misleading.
G. ABSENCE OF CERTAIN CHANGES. Since June 30, 1996, there has been
no material adverse change and no material adverse development in the business,
properties, operations, condition (financial or other), results of operations or
prospects of the Company and its subsidiaries taken as a whole.
H. ABSENCE OF LITIGATION. Except as set forth in its Form 10-K for
the year ended June 30, 1996 and in subsequent reports on Form 10-Q, there is no
action suit, proceeding, inquiry or investigation before or by any court, public
board or body pending or, to the knowledge of the Company, threatened against or
affecting the Company, wherein an unfavorable decision, ruling or finding would
have a Material Adverse Effect or which would adversely affect the validity or
enforceability of, or the authority or ability of the Company to perform its
obligations under, this Agreement or any of the documents contemplated herein.
I. LISTING. The Common Stock is listed for trading on the Nasdaq
National Market ("Nasdaq"), the Company and the Common Stock meet the criteria
for continued listing and trading on Nasdaq and no suspension of trading in the
Common Stock is in effect and its subsidiaries taken as a whole.
J. APPROVALS. No authorization, approval or consent of, or filing
with, any court, governmental body, regulatory agency, self-regulatory
organization, or stock exchange or market or the stockholders of the Company is
required to be obtained or made by the Company for (x) the issuance and sale of
7
<PAGE>
the Preferred Shares as contemplated by this Agreement and (y) the issuance of
the Registrable Securities in accordance with the terms of the Preferred Shares,
other than (1) listing of the Registrable Securities on Nasdaq, (2) filing of
the Certificate of Designation with the Secretary of State of the State of
Delaware, (3) filing of the Form D with the SEC and (4) the requirements of any
applicable blue sky laws.
4. CERTAIN COVENANTS.
-----------------
A. BEST EFFORTS. Each of the parties shall use its best efforts
timely to satisfy each of the conditions to the other party's obligations to
sell and purchase the Preferred Shares described in Section 6 or Section 7, as
the case may be, of this Agreement.
B. FORM D. The Company agrees to file a Form D with respect to the
Preferred Shares as required under Regulation D and to provide a copy thereof to
the Buyer promptly after such filing.
C. REPORTING STATUS. Until the earlier of (i) the date as of which
the Investors (as that term is defined in the Registration Rights Agreement) may
sell all of the Registrable Securities without restriction pursuant to Rule
144(k) promulgated under the 1933 Act (or successor thereto), or (ii) the date
on which (A) the Investors have sold all the Registrable Securities and (B) none
of the Preferred Shares is outstanding (the "Registration Period"), the Company
shall file all reports required to be filed with the SEC pursuant to the 1934
Act, and the Company shall not terminate its status as an issuer required to
file reports under the 1934 Act even if the 1934 Act or the rules and
regulations thereunder would permit such termination.
D. USE OF PROCEEDS. The Company will use the proceeds from the sale
of the Preferred Shares for the Company's working capital purposes and shall
not, directly or indirectly, use such proceeds for any loan to or investment in
any other corporation, partnership, enterprise or other person unrelated to the
business and direct operations of the Company or for repayment of any existing
debt obligations.
E. FINANCIAL INFORMATION. The Company agrees to send the following
reports to the Buyer during the Registration Period: (i) within five (5) days
after the filing thereof with the SEC, a copy of its Annual Report on Form 10-K,
its Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K; and (ii)
within one day after release thereof, copies of all press releases issued by the
Company or any of its subsidiaries.
F. RESERVATION OF SHARES. The Company shall at all times have
authorized, and reserved for the purpose of issuance, a sufficient number of
shares of Common Stock to provide for the issuance of Conversion Shares, the
Dividend Shares and the Additional Shares. The Company acknowledges that it
currently has an insufficient number of authorized shares of Common Stock
available for such issuances and agrees to take all steps reasonably necessary
to gain approval by its stockholders of an increase in the number of its
authorized shares of Common Stock, from 50,000,000 to 75,000,000 shares, at its
Annual Meeting of Stockholders to be held on February 28, 1997.
8
<PAGE>
G. LISTING. The Company shall promptly secure the listing of the
Registrable Securities upon each national securities exchange or automated
quotation system, if any, upon which shares of Common Stock are then listed
(subject to official notice of issuance) and shall maintain, so long as any
other shares of Common Stock shall be so listed, such listing of all shares of
Registrable Securities from time to time issuable under the terms of this
Agreement and the Registration Rights Agreement.
H. PRE-CLOSING ACTIVITY. The Buyer shall not trade in the Common
Stock for the period of five (5) trading days immediately preceding the Closing
Date.
I. STOCKHOLDER APPROVAL. (i) The Company covenants and agrees that
it shall promptly seek and use its best efforts to obtain, within 75 days
following the date of original issuance of the Preferred Shares, approval by its
stockholders of the specific transactions contemplated by this Agreement (the
"Transactions") in accordance with Delaware law. The Company shall provide
copies of its preliminary proxy materials to Buyer and its legal counsel a
reasonable period of time prior to their filing with the SEC. The Company shall
promptly furnish Buyer and its counsel with a copy of its definitive proxy
materials and any amendments or supplements thereto. If for any reason the
Company fails to obtain such stockholder approval of the Transactions within the
75-day period specified above, the Buyer shall be entitled to receive the cash
amount of liquidated damages specified in Section 4(i)(iii) below in addition to
its other applicable rights and remedies, subject to Section 4(i)(iv) below.
(ii) Unless the Company obtains Stockholder Approval (as defined
herein) or a waiver thereof from the National Association of Securities Dealers,
Inc. ("Nasdaq"), the Company will not issue any shares of Common Stock or shares
of any other series of preferred stock or other securities convertible into,
exchangeable for, or otherwise entitling the holder to acquire, shares of Common
Stock which would be subject to Rule 4460(i) of Nasdaq (or any successor or
replacement provision thereof) and which would be integrated with the sale of
the Preferred Shares to the Buyer or the issuance of Common Stock upon
conversion thereof for purposes of Rule 4460(i) of Nasdaq (or any successor or
replacement provision thereof). The Company agrees that it will not exercise its
right to permit conversion of Preferred Shares pursuant to Sections 2 or 3 of
the Certificate of Designations if such conversions would result in issuance of
a number of shares of Common Stock in excess of that permitted by Rule 4460(i)
of Nasdaq without obtaining Stockholder Approval. As used in this Section 4(i),
"Stockholder Approval" means the approval by a majority of the votes cast by the
holders of shares of Common Stock (in person or by proxy) at a meeting of the
stockholders of the Company (duly convened at which a quorum was present), or a
written consent of holders of shares of Common Stock entitled to such number of
votes given without a meeting, of the issuance by the Company of 20% or more of
the outstanding Common Stock of the Company for less than the greater of the
book or market value of such Common Stock on conversion of the Preferred Shares,
as and to the extent required under Section 4460(i)(1)(D) of the rules of Nasdaq
(or any successor or replacement provision thereof).
(iii) If at any time the Company is obligated by Rule 4460(i) of
Nasdaq to obtain Stockholder Approval, and Stockholder Approval is not obtained
9
<PAGE>
or the Company abandons its efforts to obtain Stockholder Approval such that the
Buyer is prevented from converting Preferred Shares at the Conversion Price, or
if the Company is obligated to pay the following cash amount pursuant to Section
4(i)(i) above, then the Company shall be obligated to pay the Buyer within five
business days of such occurrence, as liquidated damages and not as a penalty, a
cash amount equal to the greater of the following:
(A) the product obtained by multiplying (1) the quotient
obtained by dividing (x) the amount determined by subtracting from
100% the applicable Conversion Percentage on the date of payment by
(y) the applicable Conversion Percentage in effect on such payment
date times (2) $5,000,000; or
(B) the product obtained by multiplying (1) the quotient
obtained by dividing (x) the amount determined by subtracting from
the Average Market Price on the date of payment the then applicable
Fixed Conversion Price by (y) the applicable Fixed Conversion Price
in effect on such payment date times (2) $5,000,000.
(iv) Following the Buyer's receipt of the cash amount referred to in
Section 4(i)(iii), notwithstanding anything to the contrary in this Agreement or
in the Certificate of Designation, the Buyer shall thereafter be able to convert
any or all of its Preferred Shares only at the conversion price provided in the
first sentence of Section 2(j) of the Certificate of Designation.
J. BLUE SKY. On or before the Closing Date, the Company shall take
such action as shall be necessary to qualify, or to obtain an exemption for, the
Securities for issuance and sale to the Buyer pursuant to this Agreement and in
accordance with the Certificate of Designation under such of the securities or
"blue sky" laws of jurisdictions in the United States as shall be applicable
thereto. The Company shall furnish copies of all filings, applications, orders
and grants or confirmations of exemptions relating to such securities or "blue
sky" laws on or before the Closing Date.
K. CERTAIN TRADING RESTRICTIONS. The Buyer agrees that, during the
period from the date the Registration Statement is first declared effective by
the SEC to the date of conversion in full or redemption of all Preferred Shares
owned by the Buyer, the Buyer shall not engage in short sales or other hedging
transactions with respect to the Common Stock; provided, however, that the Buyer
may enter into such transactions involving a number of shares of Common Stock
not to exceed the number of Conversion Shares for which a Conversion Notice has
been submitted to the Company.
5. TRANSFER AGENT INSTRUCTIONS.
---------------------------
Prior to the Closing Date, the Company shall irrevocably instruct
its transfer agent to issue certificates, registered in the name of the Buyer or
its nominee, for the Conversion Shares and Additional Shares in such amounts as
specified from time to time by the Buyer to the Company. Prior to registration
of the Registrable Securities pursuant to an effective registration statement,
all such certificates shall bear the restrictive legend specified in Section
10
<PAGE>
2(g) of this Agreement. The Company shall provide instructions and opinions of
counsel to its transfer agent in accordance with Section 3(n) of the
Registration Rights Agreement. The Company warrants that no instruction other
than such instructions referred to in this Section 5, and stop-transfer
instructions to give effect to Section 2(f) hereof, in the case of the
Registrable Securities, prior to registration of the Registrable Securities
under the 1933 Act, will be given by the Company to its transfer agent and that
the Preferred Shares and the Registrable Securities shall otherwise be freely
transferable on the books and records of the Company as and to the extent
provided in this Agreement and the Registration Rights Agreement. Nothing in
this Section shall affect in any way the Buyer's obligations and agreements to
comply with all applicable securities laws upon resale of the Registrable
Securities. If the Buyer provides the Company with an opinion of counsel,
reasonably satisfactory in form, scope and substance to the Company, that
registration of a resale by the Buyer of any of the Preferred Shares or the
Registrable Securities is not required under the 1933 Act, the Company shall
permit the transfer, and promptly instruct its transfer agent to issue one or
more certificates in such name and in such denominations as specified by the
Buyer.
6. CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.
----------------------------------------------
The obligation of the Company hereunder to sell the Preferred Shares
is subject to the satisfaction, at or before the Closing Date, of each of the
following conditions, provided that these conditions are for the Company's sole
benefit and may be waived by the Company at any time in its sole discretion:
a. The Certificate of Designation shall have been filed with the
Secretary of State of the State of Delaware.
b. The Buyer shall have delivered the Purchase Price to the Escrow
Agent by wire transfer of immediately available funds pursuant to the wiring
instructions provided by the Escrow Agent.
c. The representations and warranties of the Buyer shall be true and
correct in all material respects as of the date when made and as of the Closing
Date as though made at that time (except for representations and warranties that
speak as of a specific date), and the Buyer shall have performed, satisfied and
complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the
Buyer at or prior to the Closing Date.
7. CONDITIONS TO THE BUYER'S OBLIGATION TO PURCHASE.
------------------------------------------------
The obligation of the Buyer to purchase the Preferred Shares is
subject to the satisfaction, at or before the Closing Date, of each of the
following conditions, provided that these conditions are for each Buyer's sole
benefit and may be waived by such Buyer at any time in its sole discretion:
a. The Registration Rights Agreement shall remain in full force and
effect.
11
<PAGE>
b. The Certificate of Designation shall have been filed with the
Secretary of State of the State of Delaware, and a copy thereof certified by
such Secretary of State shall have been delivered to the Buyer.
c. The representations and warranties of the Company shall be true
and correct in all material respects as of the date when made and as of the
Closing Date as though made at that time (except for representations and
warranties that speak as of a specific date) and the Company shall have
performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied
or complied with by the Company at or prior to the Closing Date. The Buyer shall
have received a certificate, executed by the Chief Financial Officer of the
Company, dated the Closing Date, to the foregoing effect and as to such other
matters as may be reasonably requested by the Buyer.
d. The Buyer shall have received the opinion of the Company's
counsel dated as of the Closing Date, in form, scope and substance reasonably
satisfactory to the Buyer and in substantially the form of EXHIBIT C.
e. The Buyer shall have received the officer's certificate described
in Section 3(c) above, dated as of the Closing Date.
g. The Company shall have executed and delivered the Stock
Certificates to the Escrow Agent.
8. MISCELLANEOUS.
-------------
A. GOVERNING LAW. This Agreement shall be governed by and
interpreted in accordance with the laws of the State of Florida without regard
to the principles of conflict of laws.
B. COUNTERPARTS. This Agreement may be executed in two or more
identical counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each
party and delivered to the other party. A facsimile transmission of this
Agreement bearing a signature on behalf of a party hereto shall be legal and
binding on such party.
C. HEADINGS. The headings in this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.
D. SEVERABILITY. If any provision of this Agreement shall be invalid
or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement or
the validity or enforceability of this Agreement in any other jurisdiction.
E. ENTIRE AGREEMENT; AMENDMENTS. This Agreement and the instruments
referenced herein contain the entire understanding of the parties with respect
to the matters covered herein and therein and, except as specifically set forth
12
<PAGE>
herein or therein, neither the Company nor the Buyer makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of
this Agreement may be waived or amended other than by an instrument in writing
signed by the party to be charged with enforcement.
F. NOTICES. Any notices required or permitted to be given under the
terms of this Agreement shall be sent by mail or delivered personally, by
courier or by telephone line facsimile transmission and shall be effective five
days after being placed in the mail, if mailed, certified, return receipt
requested, or upon receipt, if delivered personally, by courier or by telephone
line facsimile transmission, in each case addressed to a party. The addresses
for such communications shall be:
If to the Company:
2343 West 76th Street
Hialeah, FL 33016
Telephone: (305) 557-6000
Facsimile: (305) 557-6931
Attention: Mr. Gerald Smith or Mr. Dennis W. Healey
With copy to:
Atlas, Pearlman, Trop & Borkson, P.A.
New River Center
200 East Las Olas Blvd.
Fort Lauderdale, FL 33331
Telephone: (954) 763-1200
Facsimile: (954) 766-7800
Attention: James Schneider, Esq.
If to the Buyer, at the address on the signature page.
With copy to:
Law Offices of Brian W Pusch
Penthouse Suite
29 West 57th Street
New York, New York 10019
Telephone: (212) 980-0408
Facsimile: (212) 980-7055
Attention: Brian W. Pusch, Esq.
Each party shall provide five days' notice to the other party of any change in
address.
13
<PAGE>
G. SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and
inure to the benefit of the parties and their respective successors and assigns.
The Company shall not assign this Agreement or any rights or obligations
hereunder. The Buyer shall have the right, prior to or after the Closing Date,
to assign it rights and obligations under this Agreement with respect to the
purchase of all or any portion of the Preferred Shares or the transfer thereof
to an investment fund, provided such assignee or transferee, by written
instrument duly executed by such assignee or transferee, assumes all obligations
of the Buyer hereunder with respect to the purchase of the portion of the
Preferred Shares so assigned or the transfer thereof and makes the same
representations and warranties with respect thereto as the Buyer makes in this
Agreement, whereupon the Buyer shall be relieved of any further obligations,
responsibilities and liabilities with respect to the Preferred Shares so
transferred or the obligation for the purchase of which has been so assigned. In
the case of any such transfer or assignment, the Company shall agree in writing
with such transferee or assignee to make available to such transferee or
assignee the benefits of the Registration Rights Agreement with respect to the
Registrable Securities issuable in respect of the Preferred Shares with respect
to which the obligations under this Agreement have been so assigned.
H. THIRD PARTY BENEFICIARIES. This Agreement is intended for the
benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.
I. SURVIVAL. The representations and warranties of the Company and
the Buyer contained in Sections 2 and 3 and the agreements and covenants set
forth herein shall survive the closing.
J. PUBLICITY. The Company and the Buyer shall have the right to
approve before issuance any press releases or any other public statements with
respect to the transactions contemplated hereby; PROVIDED, HOWEVER, that the
Company shall be entitled, without the prior approval of the Buyer, to make any
press release with respect to such transactions as is required by applicable law
and regulations (although the Buyer shall be consulted by the Company in
connection with any such press release prior to its release and shall be
provided with a copy thereof).
L. FURTHER ASSURANCES. Each party shall do and perform, or cause to
be done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.
M. TERMINATION. In the event that the closing shall not have
occurred on or before five (5) days after the date scheduled in accordance with
Section 1(c), the Buyer shall have the right to terminate this Agreement by
notice to the Company, whereupon the Registration Rights Agreement shall
terminate and the Company and the Buyer shall have no further obligations or
liabilities, one to the other, under this Agreement or the Registration Rights
Agreement or in connection with the transactions contemplated hereby or thereby
14
<PAGE>
except for liabilities or obligations relating to any breach of this Agreement
or the Registration Rights Agreement which occurred prior to such termination.
15
<PAGE>
IN WITNESS WHEREOF, the Buyer and the Company have caused this
Securities Purchase Agreement to be duly executed by their respective officers
thereunder duly authorized as of the date first written above.
VIRAGEN, INC.
By:
Name:
Title:
STATE CAPITAL MARKET GROUP,
LTD.
By:
Name:
Title:
Address: 545 Madison Avenue
16th Floor
New York, New York 10022
Facsimile No.: (212) 888-7054
Preferred Shares: 5,000 Preferred Shares
16
<PAGE>
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT, dated as of December 31,
1996 (this "Agreement"), by and among VIRAGEN, INC., a Delaware corporation,
with headquarters located at 2343 West 76th Street, Hialeah, FL 33016 (the
"Company"), and the undersigned (the "Buyer").
WHEREAS:
A. In connection with the Securities Purchase Agreement, dated as of
the date hereof, by and between the parties (the "Securities Purchase
Agreement"), the Company has agreed, upon the terms and subject to the
conditions of the Securities Purchase Agreement to issue and sell to the Buyer
shares (the "Preferred Shares") of the Company's 5% Cumulative Convertible
Preferred Stock, Series E, $1.00 par value, which will be convertible into
shares (the "Conversion Shares") of the Company's Common Stock, $.01 par value
(the "Common Stock"), and pursuant to which certain shares of Common Stock may
be issued to the Buyer in payment of dividends (the "Dividend Shares") and in
accordance with the Certificate of Designation (the "Additional Shares"); and
B. To induce the Buyer to execute and deliver the Securities
Purchase Agreement, the Company has agreed to provide certain registration
rights under the Securities Act of 1933, as amended, and the rules and
regulations thereunder, or any similar successor statute (collectively, the
"1933 Act"), and applicable state securities laws;
NOW, THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the Company and the
Buyer hereby agree as follows:
1. DEFINITIONS.
-----------
a. As used in this Agreement, the following terms shall have the
following meanings:
(i) "Investor" means the Buyer and any transferee or assignee
thereof who agrees to become bound in writing by the provisions of this
Agreement in accordance with Section 9 hereof.
(ii) "register," "registered," and "registration" refer to a
registration effected by preparing and filing a Registration Statement or
Statements in compliance with the 1933 Act and pursuant to Rule 415 under the
1933 Act or any successor rule providing for offering securities on a continuous
basis ("Rule 415"), and the declaration or ordering of effectiveness of such
Registration Statement by the United States Securities and Exchange Commission
(the "SEC").
(iii) "Registrable Securities" means the Conversion Shares, the
Dividend Shares and the Additional Shares.
<PAGE>
(iv) "Registration Statement" means a registration statement of the
Company under the 1933 Act.
b. Capitalized terms used herein and not otherwise defined herein
shall have the respective meanings set forth in the Securities Purchase
Agreement.
2. REGISTRATION.
------------
A. MANDATORY REGISTRATION. The Company shall prepare, and, on or
before the date which is 30 days after the Closing Date, file with the SEC a
Registration Statement on Form S-3 covering the resale of at least 3,000,000
shares of Common Stock as Registrable Securities, which Registration Statement
shall state that, in accordance with Rule 416 promulgated under the 1933 Act,
such Registration Statement also covers such indeterminate number of additional
shares of Common Stock as may become issuable upon conversion of the Preferred
Shares to prevent dilution resulting from stock splits, stock dividends or
similar transactions. No securities other than the Registrable Securities shall
be registered for sale on such Registration Statement.
B. PIGGY-BACK REGISTRATIONS. If at any time prior to the expiration
of the Registration Period (as hereinafter defined) the Company shall file with
the SEC a Registration Statement relating to an offering for its own account or
the account of others under the 1933 Act of any of its equity securities (other
than on Form S-4 or Form S-8 or their then equivalents relating to equity
securities to be issued solely in connection with any acquisition of any entity
or business or equity securities issuable in connection with stock option or
other employee benefit plans) the Company shall send to each Investor who is
entitled to registration rights under this Section 2(b) written notice of such
determination and, if within twenty (20) days after receipt of such notice, such
Investor shall so request in writing, the Company shall include in such
Registration Statement all or any part of the Registrable Securities such
Investor requests to be registered, except that if, in connection with any
underwritten public offering for the account of the Company the managing
underwriter(s) thereof shall impose a limitation on the number of shares of
Common Stock which may be included in the Registration Statement because, in
such underwriter(s)' reasonable good faith judgment, marketing or other factors
dictate such limitation is necessary to facilitate public distribution, then the
Company shall be obligated to include in such Registration Statement only such
limited portion of the Registrable Securities with respect to which such
Investor has requested inclusion hereunder; provided that no portion of the
equity securities which the Company is offering for its own account shall be
excluded; PROVIDED, FURTHER that the Company shall be entitled to exclude
Registrable Securities to the extent necessary to avoid breaching obligations
existing prior to the date hereof to other stockholders of the Company. Any
exclusion of Registrable Securities shall be made pro rata among the Investors
seeking to include Registrable Securities, in proportion to the number of
Registrable Securities sought to be included by such Investors; PROVIDED,
HOWEVER, that the Company shall not exclude any Registrable Securities unless
the Company has first excluded all outstanding securities, the holders of which
are not entitled to inclusion of such securities in such Registration Statement
or are not entitled to pro rata inclusion with the Registrable Securities; and
PROVIDED, FURTHER, HOWEVER, that, after giving effect to the immediately
2
<PAGE>
preceding proviso, any exclusion of Registrable Securities shall be made pro
rata with holders of other securities having the right to include such
securities in the Registration Statement other than holders of securities
entitled to inclusion of their securities in such Registration Statement by
reason of demand registration rights. No right to registration of Registrable
Securities under this Section 2(c) shall be construed to limit any registration
required by Section 2(a) hereof. The obligations of the Company under this
Section 2(c) may be waived by Investors holding a majority in interest of the
Registrable Securities. If an offering in connection with which an Investor is
entitled to registration under this Section 2(c) is an underwritten offering,
then each Investor whose Registrable Securities are included in such
Registration Statement shall, unless otherwise agreed by the Company, offer and
sell such Registrable Securities in an underwritten offering using the same
underwriter or underwriters and, subject to the provisions of this Agreement, on
the same terms and conditions as other shares of Common Stock included in such
underwritten offering.
C. ELIGIBILITY FOR FORM S-3. The Company represents and warrants
that it meets the requirements for the use of Form S-3 for registration of the
sale by the Buyer and any other Investor of the Registrable Securities and the
Company covenants and agrees that it shall file all reports required to be filed
by the Company with the SEC in a timely manner so as to maintain such
eligibility for the use of Form S-3. In the event that Form S-3 is not available
for sale by the Investors of the Registrable Securities, the Company shall
register the sale on another appropriate form.
3. OBLIGATIONS OF THE COMPANY.
--------------------------
In connection with the registration of the Registrable Securities,
the Company shall have the following obligations:
a. The Company shall prepare promptly, and file with the SEC not
later than 30 days after the Closing Date, a Registration Statement with respect
to the number of Registrable Securities provided in Section 2(a), and thereafter
use its best efforts to cause such Registration Statement relating to
Registrable Securities to become effective as soon as possible after such
filing, and shall keep the Registration Statement effective pursuant to Rule 415
and available for use at all times until the earlier of (i) the date as of which
the Investors may sell all of the Registrable Securities without restriction
pursuant to Rule 144(k) promulgated under the 1933 Act (or successor thereto),
or (ii) the date on which (A) the Investors have sold all the Registrable
Securities and (B) none of the Preferred Shares is outstanding (the period until
such earlier date being referred to herein as the "Registration Period"), which
Registration Statement (including any amendments or supplements thereto and
prospectuses contained therein) shall not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein, or
necessary to make statements therein, in light of the circumstances in which
they were made, not misleading.
b. The Company shall prepare and file with the SEC such amendments
(including post-effective amendments) and supplements to the Registration
Statement and the prospectus used in connection with the Registration Statement
as may be necessary to keep the Registration Statement effective at all times
3
<PAGE>
during the Registration Period, and, during such period, comply with the
provisions of the 1933 Act with respect to the disposition of all Registrable
Securities of the Company covered by the Registration Statement until such time
as all of such Registrable Securities have been disposed of in accordance with
the intended methods of disposition by the seller or sellers thereof as set
forth in the Registration Statement.
c. The Company shall furnish to each Investor whose Registrable
Securities are included in the Registration Statement and its legal counsel (i)
promptly after the same is prepared and publicly distributed, filed with the
SEC, or received by the Company, one copy of the Registration Statement and any
amendment thereto, each preliminary prospectus and prospectus and each amendment
or supplement thereto, and (ii) such number of copies of a prospectus, including
a preliminary prospectus, and all amendments and supplements thereto and such
other documents as such Investor may reasonably request in order to facilitate
the disposition of the Registrable Securities owned by such Investor.
d. In the case of the Registration Statement referred to in Section
2(a), the Company shall furnish to the counsel of each Investor each letter
written by or on behalf of the Company to the SEC or the staff of the SEC, and
each item of correspondence from the SEC or the staff of the SEC, in each case
relating to such Registration Statement (other than any portion of any thereof
which contains information for which the Company has sought confidential
treatment).
e. The Company shall use reasonable efforts to (i) register and
qualify the Registrable Securities covered by the Registration Statement under
such other securities or "blue sky" laws of such jurisdictions in the United
States as the Investors who hold a majority in interest of the Registrable
Securities being offered reasonably request, (ii) prepare and file in those
jurisdictions such amendments (including post-effective amendments) and
supplements to such registrations and qualifications as may be necessary to
maintain the effectiveness thereof during the Registration Period, (iii) take
such other actions as may be reasonably necessary to maintain such registrations
and qualifications in effect at all times during the Registration Period, and
(iv) take all other actions reasonably necessary or advisable to qualify the
Registrable Securities for sale in such jurisdictions; PROVIDED, HOWEVER, that
the Company shall not be required in connection therewith or as a condition
thereto to (a) qualify to do business in any jurisdiction where it would not
otherwise be required to qualify but for this Section 3(e), (b) subject itself
to general taxation in any such jurisdiction, (c) file a general consent to
service of process in any such jurisdiction, (d) provide any undertakings that
cause more than nominal expense or burden to the Company, or (e) make any change
in its charter or bylaws, which in each case the Board of Directors of the
Company determines to be contrary to the best interests of the Company and its
stockholders.
f. As promptly as practicable after becoming aware of such event,
the Company shall notify each Investor of the happening of any event, of which
the Company has knowledge, as a result of which the prospectus included in the
Registration Statement, as then in effect, includes an untrue statement of a
material fact or omission to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, and use its best efforts promptly to
4
<PAGE>
prepare a supplement or amendment to the Registration Statement to correct such
untrue statement or omission, and deliver such number of copies of such
supplement or amendment to each Investor as such Investor may reasonably
request.
g. The Company shall use its best efforts to prevent the issuance of
any stop order or other suspension of effectiveness of a Registration Statement,
and, if such an order is issued, to obtain the withdrawal of such order at the
earliest possible moment and to notify each Investor who holds Registrable
Securities being sold (or, in the event of an underwritten offering, the
managing underwriters) of the issuance of such order and the resolution thereof.
h. The Company shall permit a single firm of counsel, designated as
selling stockholders' counsel by the Investors who hold a majority in interest
of the Registrable Securities being sold, to review and comment upon the
Registration Statement, all amendments and supplements thereto and any
acceleration request relating thereto a reasonable period of time prior to their
filing with or submission to the SEC, and shall not file any such document in a
form to which such counsel reasonably objects, in each case so long as such
counsel responds to the Company or its counsel within 72 hours after delivery of
such item to them by the Company.
i. The Company shall make generally available to its security
holders as soon as practicable, but not later than ninety (90) days after the
close of the period covered thereby, an earnings statement (in form complying
with the provisions of Rule 158 under the 1933 Act) covering a twelve-month
period beginning not later than the first day of the Company's fiscal quarter
next following the effective date of the Registration Statement.
j. The Company shall make available for inspection by (i) any
Investor and (ii) one firm of attorneys and one firm of accountants or other
agents retained by the Investors (collectively, the "Inspectors") all pertinent
financial and other records, and pertinent corporate documents and properties of
the Company (collectively, the "Records"), as shall be reasonably deemed
necessary by each Inspector to enable each Inspector to exercise its due
diligence responsibility, and cause the Company's officers, directors and
employees to supply all information which any Inspector may reasonably request
for purposes of due diligence; PROVIDED, HOWEVER, that each Inspector shall hold
in confidence and shall not make any disclosure (except to an Investor) of any
Record or other information which the Company determines in good faith to be
confidential, and of which determination the Inspectors are so notified, unless
(a) the disclosure of such Records is necessary to avoid or correct a
misstatement or omission in any Registration Statement, (b) the release of such
Records is ordered pursuant to a subpoena or other final, non-appealable order
from a court or government body of competent jurisdiction, or (c) the
information in such Records has been made generally available to the public
other than by disclosure in violation of this or any other agreement. The
Company shall not be required to disclose any confidential information in such
Records to any Inspector until and unless such Inspector shall have entered into
confidentiality agreements (in form and substance satisfactory to the Company)
with the Company with respect thereto, substantially in the form of this Section
3(j). Each Investor agrees that it shall, upon learning that disclosure of such
Records is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt notice to the Company and allow
5
<PAGE>
the Company, at its expense, to undertake appropriate action to prevent
disclosure of, or to obtain a protective order for, the Records deemed
confidential.
k. The Company shall hold in confidence and not make any disclosure
of information concerning an Investor provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state
securities laws, (ii) the disclosure of such information is necessary to avoid
or correct a misstatement or omission in any Registration Statement, (iii) the
release of such information is ordered pursuant to a subpoena or other final,
non-appealable order from a court or governmental body of competent
jurisdiction, or (iv) such information has been made generally available to the
public other than by disclosure in violation of this or any other agreement. The
Company agrees that it shall, upon learning that disclosure of such information
concerning an Investor is sought in or by a court or governmental body of
competent jurisdiction or through other means, give prompt notice to such
Investor and allow such Investor, at the Investor's expense, to undertake
appropriate action to prevent disclosure of, or to obtain a protective order
for, such information.
l. The Company shall use its best efforts either to (i) cause all
the Registrable Securities covered by the Registration Statement to be listed on
a national securities exchange and on each additional national securities
exchange on which securities of the same class or series issued by the Company
are then listed, if any, if the listing of such Registrable Securities is then
permitted under the rules of such exchange, or (ii) secure designation and
quotation of all the Registrable Securities covered by the Registration
Statement on the National Market of the National Association of Securities
Dealers Automated Quotation ("NASDAQ") System or, if, despite the Company's best
efforts to satisfy the preceding clause (i) or (ii), the Company is unsuccessful
in satisfying the preceding clause (i) or (ii), to secure the inclusion for
quotation on the NASDAQ SmallCap Market for such Registrable Securities and,
without limiting the generality of the foregoing, to arrange for at least two
market makers to register with the National Association of Securities Dealers,
Inc. ("NASD") as such with respect to such Registrable Securities.
m. The Company shall provide a transfer agent and registrar, which
may be a single entity, for the Registrable Securities, and shall provide CUSIP
numbers for the Registrable Securities, not later than the effective date of the
Registration Statement.
n. The Company shall cooperate with the Investors who hold
Registrable Securities being offered and the managing underwriter or
underwriters, if any, to facilitate the timely preparation and delivery of
certificates (not bearing any restrictive legends) representing Registrable
Securities to be offered pursuant to the Registration Statement and enable such
certificates to be in such denominations or amounts as the case may be, as the
Investors may reasonably request and registered in such names as the Investors
may request; and, within three business days after a Registration Statement
which includes Registrable Securities is ordered effective by the SEC, the
Company shall deliver, and shall cause legal counsel selected by the Company to
deliver, to the transfer agent for the Registrable Securities (with copies to
the Investors whose Registrable Securities are included in such Registration
6
<PAGE>
Statement) an instruction substantially in the form attached hereto as EXHIBIT 1
and an opinion of such counsel in the form attached hereto as EXHIBIT 2.
o. During the Registration Period, the Company shall not bid for or
purchase any Common Stock or any right to purchase Common Stock or attempt to
induce any person to purchase any such security or right if such bid, purchase
or attempt would in any way limit the right of the Investors to sell Registrable
Securities by reason of the limitations in Rule 10b-6 under the Securities
Exchange Act of 1934, as amended (the "1934 Act"), so long as such rule remains
in effect, or Regulation M under the 1934 Act once such regulation goes into
effect.
p. The Company shall take all other actions reasonably necessary to
expedite and facilitate the disposition by the Investors of Registrable
Securities pursuant to the Registration Statement.
4. OBLIGATIONS OF THE INVESTORS.
----------------------------
In connection with the registration of the Registrable Securities,
the Investors shall have the following obligations:
a. It shall be a condition precedent to the obligations of the
Company to complete the registration pursuant to this Agreement with respect to
the Registrable Securities of a particular Investor that such Investor shall
furnish to the Company such information regarding itself, the Registrable
Securities held by it and the intended method of disposition of the Registrable
Securities held by it as shall be reasonably required to effect the registration
of such Registrable Securities and shall execute such documents in connection
with such registration as the Company may reasonably request. At least five (5)
days prior to the first anticipated filing date of the Registration Statement,
the Company shall notify each Investor of the information the Company requires
from each such Investor if such Investor elects to have any of such Investor's
Registrable Securities included in the Registration Statement.
b. Each Investor by such Investor's acceptance of the Registrable
Securities agrees to cooperate with the Company as reasonably requested by the
Company in connection with the preparation and filing of the Registration
Statement hereunder, unless such Investor has notified the Company in writing of
such Investor's election to exclude all of such Investor's Registrable
Securities from the Registration Statement.
c. In the event Investors holding a majority in interest of the
Registrable Securities being registered determine to engage the services of an
underwriter, each Investor agrees to enter into and perform such Investor's
obligations under an underwriting agreement, in usual and customary form,
including, without limitation, customary indemnification and contribution
obligations, with the managing underwriter of such offering and take such other
actions as are reasonably required in order to expedite or facilitate the
disposition of the Registrable Securities, unless such Investor has notified the
Company in writing of such Investor's election to exclude all of such Investor's
Registrable Securities from the Registration Statement.
7
<PAGE>
d. Each Investor agrees that, upon receipt of any notice from the
Company of the happening of any event of the kind described in Section 3(f) or
3(g), such Investor will immediately discontinue disposition of Registrable
Securities pursuant to the Registration Statement covering such Registrable
Securities until such Investor's receipt of the copies of the supplemented or
amended prospectus contemplated by Section 3(f) or 3(g) and, if so directed by
the Company, such Investor shall deliver to the Company (at the expense of the
Company) or destroy (and deliver to the Company a certificate of destruction)
all copies in such Investor's possession, of the prospectus covering such
Registrable Securities current at the time of receipt of such notice.
e. No Investor may participate in any underwritten registration
hereunder unless such Investor (i) agrees to sell such Investor's Registrable
Securities on the basis provided in any underwriting arrangements approved by
the Investors entitled hereunder to approve such arrangements, (ii) completes
and executes all questionnaires, powers of attorney, indemnities, underwriting
agreements and other documents reasonably required under the terms of such
underwriting arrangements, and (iii) agrees to pay its pro rata share of all
underwriting discounts and commissions.
5. EXPENSES OF REGISTRATION.
------------------------
All reasonable expenses, other than underwriting discounts and
commissions and other fees and expenses of investment bankers and counsel
retained by any Investor and other than brokerage commissions of the Investors,
incurred in connection with registrations, filings or qualifications pursuant to
Section 3, including, without limitation, all registration, listing and
qualifications fees, printers and accounting fees and the fees and disbursements
of counsel for the Company, shall be borne by the Company.
6. INDEMNIFICATION.
---------------
In the event any Registrable Securities are included in a
Registration Statement under this Agreement:
a. To the extent permitted by law, the Company will indemnify, hold
harmless and defend (i) each Investor who holds such Registrable Securities and
(ii) the directors, officers and each person who controls any Investor within
the meaning of the 1933 Act or the 1934 Act, if any, (each, an "Indemnified
Person"), against any losses, claims, damages, liabilities or expenses (joint or
several) (collectively, "Claims") to which any of them may become subject
insofar as such Claims (or actions or proceedings, whether commenced or
threatened, in respect thereof) arise out of or are based upon: (i) any untrue
statement or alleged untrue statement of a material fact in a Registration
Statement or the omission or alleged omission to state a material fact therein
required to be stated or necessary to make the statements therein not
misleading, (ii) any untrue statement or alleged untrue statement of a material
fact contained in any preliminary prospectus if used prior to the effective date
of such Registration Statement, or contained in the final prospectus (as amended
or supplemented, if the Company files any amendment thereof or supplement
thereto with the SEC) or the omission or alleged omission to state therein any
8
<PAGE>
material fact necessary to make the statements made therein, in light of the
circumstances under which the statements therein were made, not misleading, or
(iii) any violation or alleged violation by the Company of the 1933 Act, the
1934 Act, any other law, including, without limitation, any state securities
law, or any rule or regulation thereunder relating to the offer or sale of the
Registrable Securities pursuant to a Registration Statement (the matters in the
foregoing clauses (i) through (iii) being, collectively, "Violations"). Subject
to the restrictions set forth in Section 6(d) with respect to the number of
legal counsel, the Company shall reimburse the Investors and each such
underwriter or controlling person, promptly as such expenses are incurred and
are due and payable, for any legal fees or other reasonable expenses incurred by
them in connection with investigating or defending any such Claim.
Notwithstanding anything to the contrary contained herein, the indemnification
agreement contained in this Section 6(a): (i) shall not apply to a Claim arising
out of or based upon a Violation which occurs in reliance upon and in conformity
with information furnished in writing to the Company by any Indemnified Person
or underwriter for such Indemnified Person expressly for use in connection with
the preparation of the Registration Statement or any such amendment thereof or
supplement thereto, if such prospectus was timely made available by the Company
pursuant to Section 3(c) hereof; (ii) with respect to any preliminary
prospectus, shall not inure to the benefit of any such person from whom the
person asserting any such Claim purchased the Registrable Securities that are
the subject thereof (or to the benefit of any person controlling such person) if
the untrue statement or omission of material fact contained in the preliminary
prospectus was corrected in the prospectus, as then amended or supplemented, if
such prospectus was timely made available by the Company pursuant to Section
3(c) hereof; (iii) shall not be available to the extent such Claim is based on a
failure of the Investor to deliver or to cause to be delivered the prospectus
made available by the Company; and (iv) shall not apply to amounts paid in
settlement of any Claim if such settlement is effected without the prior written
consent of the Company, which consent shall not be unreasonably withheld. Such
indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of the Indemnified Person and shall survive the transfer of
the Registrable Securities by the Investors pursuant to Section 9.
b. In connection with any Registration Statement in which an
Investor is participating, each such Investor agrees to indemnify, hold harmless
and defend, to the same extent and in the same manner set forth in Section 6(a),
the Company, each of its directors, each of its officers who signs the
Registration Statement, each person, if any, who controls the Company within the
meaning of the 1933 Act or the 1934 Act, any underwriter and any other
stockholder selling securities pursuant to the Registration Statement or any of
its directors or officers or any person who controls such stockholder or
underwriter within the meaning of the 1933 Act or the 1934 Act (collectively and
together with an Indemnified Person, an "Indemnified Party"), against any Claim
to which any of them may become subject, under the 1933 Act, the 1934 Act or
otherwise, insofar as such Claim arises out of or is based upon any Violation,
in each case to the extent (and only to the extent) that such violation occurs
in reliance upon and in conformity with written information furnished to the
Company by such Investor expressly for use in connection with such Registration
Statement or to the extent such Claim is based upon any violation or alleged
violation by the Investor of the 1933 Act, 1934 Act or any other law; and such
Investor will reimburse any legal or other expenses reasonably incurred by them
9
<PAGE>
in connection with investigating or defending any such Claim; PROVIDED, HOWEVER,
that the indemnity agreement contained in this Section 6(b) shall not apply to
amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of such Investor, which consent shall not be
unreasonably withheld; PROVIDED, FURTHER, HOWEVER, that the Investor shall be
liable under this Section 6(b) for only that amount of a Claim as does not
exceed the net proceeds to such Investor as a result of the sale of Registrable
Securities pursuant to such Registration Statement. Such indemnity shall remain
in full force and effect regardless of any investigation made by or on behalf of
such Indemnified Party and shall survive the transfer of the Registrable
Securities by the Investors pursuant to Section 9. Notwithstanding anything to
the contrary contained herein, the indemnification agreement contained in this
section 6(b) with respect to any preliminary prospectus shall not inure to the
benefit of any Indemnified Party if the untrue statement or omission of material
fact contained in the preliminary prospectus was corrected on a timely basis in
the prospectus, as then amended or supplemented.
c. The Company shall be entitled to receive indemnities from
underwriters, selling brokers, dealer managers and similar securities industry
professionals participating in any distribution, to the same extent as provided
above, with respect to information such person so furnished in writing by such
persons expressly for inclusion in the Registration Statement.
d. Promptly after receipt by an Indemnified Person or Indemnified
Party under this Section 6 of notice of the commencement of any action
(including any governmental action), such Indemnified Person or Indemnified
Party shall, if a Claim in respect thereof is made against any indemnifying
party under this Section 6, deliver to the indemnifying party a written notice
of the commencement thereof, and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly noticed, to assume control of the
defense thereof with counsel mutually satisfactory to the indemnifying party and
the Indemnified Person or the Indemnified Party, as the case may be; PROVIDED,
HOWEVER, that an Indemnified Person or Indemnified Party shall have the right to
retain its own counsel with the fees and expenses to be paid by the indemnifying
party, if, in the reasonable opinion of counsel retained by the indemnifying
party, the representation by such counsel of the Indemnified Person or
Indemnified Party and the indemnifying party would be inappropriate due to
actual or potential differing interests between such Indemnified Person or
Indemnified Party and any other party represented by such counsel in such
proceeding. The Company shall pay reasonable fees for only one separate legal
counsel for the Investors, and such legal counsel shall be selected by the
Investors holding a majority in interest of the Registrable Securities included
in the Registration Statement to which the Claim relates; provided, that legal
fees of such firm shall be reasonable. The failure to deliver written notice to
the indemnifying party within a reasonable time of the commencement of any such
action shall not relieve such indemnifying party of any liability to the
Indemnified Person or Indemnified Party under this Section 6, except to the
extent that the indemnifying party is prejudiced in its ability to defend such
action. The indemnification required by this Section 6 shall be made by periodic
payments of the amount thereof during the course of the investigation or
defense, as such expense, loss, damage or liability is incurred and is due and
payable.
10
<PAGE>
7. CONTRIBUTION.
------------
To the extent any indemnification by an indemnifying party is
prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable
under Section 6 to the fullest extent permitted by law; PROVIDED, HOWEVER, that
(i) no contribution shall be made under circumstances where the maker would not
have been liable for indemnification under the fault standards set forth in
Section 6, (ii) no seller of Registrable Securities guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be
entitled to contribution from any seller of Registrable Securities who was not
guilty of such fraudulent misrepresentation, and (iii) contribution by any
seller of Registrable Securities shall be limited in amount to the net amount of
proceeds received by such seller from the sale of such Registrable Securities.
8. REPORTS UNDER THE 1934 ACT.
--------------------------
With a view to making available to the Investors the benefits of
Rule 144 promulgated under the 1933 Act or any other similar rule or regulation
of the SEC that may at any time permit the investors to sell securities of the
Company to the public without registration ("Rule 144"), the Company agrees to:
a. make and keep public information available, as those terms are
understood and defined in Rule 144;
b. file with the SEC in a timely manner all reports and other
documents required of the Company under the 1933 Act and the 1934 Act so long as
the Company remains subject to such requirements (it being understood that
nothing herein shall limit the Company's obligations under Section 4(c) of the
Securities Purchase Agreement) and the filing of such reports and other
documents is required for the applicable provisions of Rule 144; and
c. furnish to each Investor so long as such Investor owns
Registrable Securities, promptly upon request, (i) a written statement by the
Company that it has complied with the reporting requirements of Rule 144, the
1933 Act and the 1934 Act, (ii) a copy of the most recent annual or quarterly
report of the Company and such other reports and documents so filed by the
Company and (iii) such other information as may be reasonably requested to
permit the investors to sell such securities pursuant to Rule 144 without
registration.
9. ASSIGNMENT OF REGISTRATION RIGHTS.
---------------------------------
The rights to have the Company register Registrable Securities
pursuant to this Agreement shall be automatically assignable by the Investors to
any transferee of all or any portion of the Preferred Shares or the Registrable
Securities if: (i) the Investor agrees in writing with the transferee or
assignee to assign such rights, and a copy of such agreement is furnished to the
Company within a reasonable time after such assignment, (ii) the Company is,
within a reasonable time after such transfer or assignment, furnished with
written notice of (a) the name and address of such transferee or assignee, and
(b) the securities with respect to which such registration rights are being
transferred or assigned, (iii) immediately following such transfer or assignment
the further disposition of such securities by the transferee or assignee is
11
<PAGE>
restricted under the 1933 Act and applicable state securities laws, (iv) at or
before the time the Company receives the written notice contemplated by clause
(ii) of this sentence the transferee or assignee agrees in writing with the
Company to be bound by all of the provisions contained herein, (v) such transfer
shall have been made in accordance with the applicable requirements of the
Securities Purchase Agreement, (vi) such transferee shall be an "accredited
investor" as that term is defined in Rule 501 of Regulation D promulgated under
the 1933 Act and (vii) in the event the assignment occurs subsequent to the date
of effectiveness of the Registration Statement required to be filed pursuant to
Section 2(a), the Company agrees to pay all its reasonable expenses of amending
or supplementing such Registration Statement to reflect such assignment.
10. AMENDMENT OF REGISTRATION RIGHTS.
--------------------------------
Provisions of this Agreement may be amended and the observance
thereof may be waived (either generally or in a particular instance and either
retroactively or prospectively), only with the written consent of the Company
and Investors who hold a majority in interest of the Registrable Securities. Any
amendment or waiver effected in accordance with this Section 10 shall be binding
upon each Investor and the Company.
11. MISCELLANEOUS.
-------------
a. A person or entity is deemed to be a holder of Registrable
Securities whenever such person or entity owns of record such Registrable
Securities. If the Company receives conflicting instructions, notices or
elections from two or more persons or entities with respect to the same
Registrable Securities, the Company shall act on the basis of instructions,
notice or election received from the registered owner of such Registrable
Securities.
b. Any notices required or permitted to be given under the terms of
this Agreement shall be sent by certified mail, return receipt requested, or
delivered personally, by courier or by telephone line facsimile transmission and
shall be effective five days after being placed in the mail, if mailed, or upon
receipt, if delivered personally, by courier or by telephone line facsimile
transmission, in each case addressed to a party. The addresses for such
communications shall be:
If to the Company:
2343 West 76th Street
Hialeah, FL 33016
Telephone: (305) 557-6000
Facsimile: (305) 557-6931
Attention: Mr. Gerald Smith or Mr. Dennis W. Healey
12
<PAGE>
With copy to:
Atlas, Pearlman, Trop & Borkson, P.A.
New River Center
200 East Las Olas Blvd.
Fort Lauderdale, FL 33331
Telephone: (954) 763-1200
Facsimile: (954) 766-7800
Attention: James Schneider, Esq.
If to the Buyer, at the addresses on the signature page.
With copy to:
Law Offices of Brian W Pusch
29 West 57th Street
Penthouse Suite
New York, New York 10019
Telephone: 980-0408
Facsimile: 980-7055
Attention: Brian W. Pusch
Each party shall provide five days' notice to the other party of any change in
address.
c. Failure of any party to exercise any right or remedy under this
Agreement or otherwise, or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof.
d. This Agreement shall be enforced, governed by and construed in
accordance with the laws of the State of Florida applicable to agreements made
and to be performed entirely within such State. In the event that any provision
of this Agreement is invalid or unenforceable under any applicable statute or
rule of law, then such provision shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed modified to conform with such
statute or rule of law. Any provision hereof which may prove invalid or
unenforceable under any law shall not affect the validity or enforceability of
any other provision hereof.
e. This Agreement and the Securities Purchase Agreement constitute
the entire agreement among the parties hereto with respect to the subject matter
hereof and thereof. There are no restrictions, promises, warranties or
undertakings, other than those set forth or referred to herein and therein. This
Agreement and the Securities Purchase Agreement supersede all prior agreements
and understandings among the parties hereto with respect to the subject matter
hereof and thereof.
f. Subject to the requirements of Section 9 hereof, this Agreement
shall inure to the benefit of and be binding upon the successors and assigns of
each of the parties hereto.
g. The headings in this Agreement are for convenience of reference
only and shall not limit or otherwise affect the meaning hereof.
13
<PAGE>
h. This Agreement may be executed in two or more counterparts, each
of which shall be deemed an original but all of which shall constitute one and
the same agreement. This Agreement, once executed by a party, may be delivered
to the other party hereto by facsimile transmission of a copy of this Agreement
bearing the signature of the party so delivering this Agreement.
i. Each party shall do and perform, or cause to be done and
performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents, as the other
party may reasonably request in order to carry out the intent and accomplish the
purposes of this Agreement and the consummation of the transactions contemplated
hereby.
14
<PAGE>
IN WITNESS WHEREOF, the parties have caused this Registration Rights
Agreement to be duly executed as of day and year first above written.
VIRAGEN, INC.
By:
Name:
Title:
STATE CAPITAL MARKET GROUP, LTD.
By:
Name:
Title:
Address: 545 Madison Avenue
16th Floor
New York, New York 10022
Facsimile No.: (212) 888-7054
15
<PAGE>
EXHIBIT 1
TO
REGISTRATION
RIGHTS AGREEMENT
[Company Letterhead]
[Date]
[Name and address of Transfer Agent]
Ladies and Gentlemen:
This letter shall serve as our irrevocable authorization and
direction to you [(1) to transfer or re-register the certificates for the shares
of Common Stock, $.01 par value (the "Common Stock"), of Viragen, Inc., a
Delaware corporation (the "Company"), represented by certificate numbers _______
and _______ for an aggregate of _______ shares (the "Outstanding Shares") of
Common Stock presently registered in the name of [Name of Investor] upon
surrender of such certificate to you, notwithstanding the legend appearing on
such certificates, and (2)][1] to issue shares (the "Conversion Shares") of
Common Stock to or upon the order of the holder from time to time on conversion
of the shares of 5% Cumulative Convertible Preferred Stock, Series E, $1.00 par
value, of the Company upon surrender to you by such registered holder a properly
completed and duly executed Conversion Notice in the form enclosed herewith.
[The transfer or re-registration of the certificates for the Outstanding Shares
by you should be made at such time as you are requested to do so by the record
holder of the Outstanding Shares. The certificate issued upon such transfer or
re-registration should be registered in such name as requested by the holder of
record of the certificate surrendered to you and should not bear any legend
which would restrict the transfer of the shares represented thereby. In
addition, you are hereby directed to remove any stop-transfer instruction
relating to the Outstanding Shares.]* Certificates for the Conversion Shares
should not bear any restrictive legend and should not be subject to any
stop-transfer restriction.
Contemporaneous with the delivery of this letter, the Company is
delivering to you an opinion of ____________________ as to registration of [the
Outstanding Shares,]* and the Conversion Shares under the Securities Act of
1933, as amended.
________________________________________
[1]
Omit if no conversion of the preferred shares has occurred before SEC
registration is declared effective.
42.28.04.03-6 1-16
16
<PAGE>
Should you have any questions concerning this matter, please contact me.
Very truly yours,
VIRAGEN, INC.
By__________________________
Name:
Title:
Enclosure
cc: [Name of Investor]
42.28.04.03-6 1-17
17
<PAGE>
EXHIBIT 2
TO
REGISTRATION
RIGHTS AGREEMENT
[Date]
[Name and address
of transfer agent]
VIRAGEN, INC.
Shares of Common Stock
----------------------
Ladies and Gentlemen:
We are counsel to Viragen, Inc., a Delaware corporation (the
"Company"), and we understand that [Name of Investor] (the "Holder") has
acquired from the Company [(1) an aggregate of shares (the "Shares") of the
Company's Common Stock, $.01 par value (the "Common Stock"), represented by
Certificate No.___ and (2)][2]______shares (the "Preferred Shares" of 5%
Cumulative Convertible Preferred Stock, Series E, $1.00 par value, issued by the
Company. The Preferred Shares were purchased by the Holder pursuant to a
Securities Purchase Agreement, dated as of December 31, 1996, between the Holder
and the Company (the "Securities Purchase Agreement"). Pursuant to a
Registration Rights Agreement, dated as of December 31, 1996, between the
Company and the Holder (the "Registration Rights Agreement") entered into in
connection with the purchase by the Holder of the Preferred Shares, the Company
agreed with the Holder, among other things, to register for resale the [Shares
and any additional]* shares of Common Stock issuable upon conversion of the
Preferred Shares (the "Conversion Shares"), in payment of dividends on the
Preferred Shares (the "Dividend Shares") or otherwise as permitted by the
Certificate of Designations, Rights and Preferences for the Preferred Shares
(the "Additional Shares") under the Securities Act of 1933, as amended (the
"Securities Act"), upon the terms provided in the Registration Rights Agreement.
Pursuant to the Registration Rights Agreement, on __________, the Company filed
a Registration Statement on Form S-3 (File No. 333-__________) (the
"Registration Statement") with the Securities and Exchange Commission (the
"SEC") relating to [the Shares,]3 the Conversion Shares, the Dividend Shares and
the Additional Shares, which names the Holder as a selling stockholder
thereunder.
[Other introductory and scope of examination language to be inserted]
_______________________________________
[2]
Omit if no conversion of the preferred shares has occurred before SEC
registration is declared effective.
42.28.04.03-6 2-18
18
<PAGE>
Based on the foregoing, we are of the opinion that [the Shares,]*
the Conversion Shares, the Dividend Shares and the Additional Shares have been
registered under the Securities Act.
This opinion may be relied upon by the Holder as if addressed to the
Holder. [Other appropriate language to be included.]
Very truly yours,
cc: [Name of Investor]
42.28.04.03-6 2-19
19
